https://curecurrent.com/trials/effect-of-biphasic-insulin-aspart-30-combined-with-metformin-on-blood-glucose-control-in-subjects-with-type-2-diabetes-i-20833 https://curecurrent.com/trials/efficacy-and-safety-comparative-study-of-sitagliptin-vildagliptin-and-saxagliptin-20834 https://curecurrent.com/trials/exit-prospective-study-of-the-response-to-exercise-20835 https://curecurrent.com/trials/glp-1-effects-on-insulin-and-glucagon-in-ptdm-20836 https://curecurrent.com/trials/shockwave-therapy-of-chronic-diabetic-foot-ulcers-20837 https://curecurrent.com/trials/the-effects-of-bindarit-in-diabetic-nephropathy-20838 https://curecurrent.com/trials/treatment-of-overweight-and-obese-children-using-the-holbaek-method-in-a-municipality-based-treatment-program-20839 https://curecurrent.com/trials/vasopressin-and-v2-receptor-in-meniere-s-disease-20840 https://curecurrent.com/trials/study-of-two-titration-algorithms-with-insulin-glargine-300-units-ml-in-type-2-diabetes-mellitus-patients-20841 https://curecurrent.com/trials/a-multiple-ascending-dose-phase-i-study-of-dbpr108-in-healthy-male-subjects-20842 https://curecurrent.com/trials/an-observational-cross-sectional-study-to-assess-the-prevalence-of-chronic-kidney-disease-ckd-in-type-2-diabetes-patient-20843 https://curecurrent.com/trials/effect-of-sglt-2-inhibitor-dapagliflozin-on-glycemic-variability-in-patients-with-diabetes-mellitus-type-2-20844 https://curecurrent.com/trials/effect-of-gastrectomy-and-anastomosis-on-diabetes-and-hypertension-in-early-gastric-cancer-patients-20845 https://curecurrent.com/trials/influence-of-liraglutide-a-glp-1-receptor-agonist-on-brown-adipose-tissue-bat-activity-in-humans-20846 https://curecurrent.com/trials/a-radiolabeled-mass-balance-study-of-14c-ertugliflozin-pf04971729-mk-8835-in-healthy-male-participants-mk-8835-038-20847 https://curecurrent.com/trials/a-phase-iiib-study-to-evaluate-the-safety-and-efficacy-of-gemigliptin-in-type-2-diabetes-mellitus-patients-with-moderate-20848 https://curecurrent.com/trials/dose-response-and-variability-of-inhaled-insulin-in-type-2-diabetes-20849 https://curecurrent.com/trials/liraglutide-efficacy-and-action-in-non-alcoholic-steatohepatitis-20850 https://curecurrent.com/trials/relationship-between-level-of-hemoglobin-a1c-and-platelet-function-in-patients-undergoing-cardiac-surgery-20851 https://curecurrent.com/trials/pharmacologic-response-and-safety-of-inhaled-insulin-in-type-1-diabetes-20852 https://curecurrent.com/trials/national-heart-lung-and-blood-institute-twin-study-20853 https://curecurrent.com/trials/efficacy-study-of-the-diamond-system-to-treat-type-2-diabetes-mellitus-20854 https://curecurrent.com/trials/glycemic-index-and-insulinemic-index-of-3-types-of-tortilla-in-mexican-adults-20855 https://curecurrent.com/trials/cardiovascular-disease-mortality-in-the-nas-nrc-twin-registry-20856 https://curecurrent.com/trials/axillary-block-properties-in-diabetic-patients-20857 https://curecurrent.com/trials/the-diamond-for-the-treatment-of-type-2-diabetes-20858 https://curecurrent.com/trials/health-coaching-to-effect-lifestyle-behaviour-change-20859 https://curecurrent.com/trials/intraarterial-infusion-of-autologous-bone-marrow-in-diabetic-patients-with-chronic-ischemia-of-lower-limbs-cli-no-revasc-20860 https://curecurrent.com/trials/va-hdl-intervention-trial-va-hit-ancillary-study-data-analysis-20861 https://curecurrent.com/trials/to-investigate-the-efficacy-and-safety-of-individualized-doses-of-biochaperone-insulin-lispro-in-comparison-to-humalog-u-20862 https://curecurrent.com/trials/impact-of-n-3-polyunsaturated-fatty-acids-in-a-protein-enriched-diet-with-low-gi-in-type-2-diabetes-patients-20863 https://curecurrent.com/trials/consequences-and-correlates-of-weight-fluctuations-20864 https://curecurrent.com/trials/sit-less-2-effect-of-sitting-less-on-glucose-regulation-in-people-with-diabetes-mellitus-type-2-20865 https://curecurrent.com/trials/comparison-of-the-change-in-fat-distribution-in-overweight-and-obese-subjects-with-type-2-diabetes-after-insulin-treatme-20866 https://curecurrent.com/trials/a-phase-1-study-in-japanese-subjects-with-type-2-diabetes-mellitus-as-monotherapy-20867 https://curecurrent.com/trials/anti-diabetic-effects-of-persimmon-leaf-extract-20868 https://curecurrent.com/trials/incretin-based-drugs-and-pancreatic-cancer-20869 https://curecurrent.com/trials/high-potency-statins-and-the-risk-of-diabetes-20870 https://curecurrent.com/trials/variation-of-glucose-values-at-early-stages-of-diabetes-continuous-glucose-monitoring-20871 https://curecurrent.com/trials/botulinum-toxin-in-peripheral-neuropathic-pain-20872 https://curecurrent.com/trials/mobile-sipoo-telemonitoring-with-combined-with-active-assistance-technology-20873 https://curecurrent.com/trials/encourage-evaluating-community-peer-advisors-and-diabetes-outcomes-in-rural-alabama-20874 https://curecurrent.com/trials/the-use-of-home-oral-glucose-tolerance-test-kit-in-screening-cystic-fibrosis-related-diabetes-20875 https://curecurrent.com/trials/ala-on-glycemic-control-in-t2dm-participants-20876 https://curecurrent.com/trials/effects-of-resveratrol-on-inflammation-in-type-2-diabetic-patients-20877 https://curecurrent.com/trials/incidence-of-diabetes-and-cardiovascular-disease-in-mexican-americans-20878 https://curecurrent.com/trials/study-of-the-mechanisms-of-metabolic-adaptations-to-overfeeding-20879 https://curecurrent.com/trials/diabetes-and-cardiovascular-risk-in-mexico-city-san-antonio-heart-study-20880 https://curecurrent.com/trials/endothelial-function-in-patients-with-type-2-diabetes-versus-healthy-subjects-20881 https://curecurrent.com/trials/a-study-of-dulaglutide-in-chinese-participants-20882 https://curecurrent.com/trials/post-marketing-surveillance-study-of-biphasic-insulin-aspart-30-20883 https://curecurrent.com/trials/evaluation-of-fenugreek-seed-extract-in-type-2-diabetes-an-add-on-study-20884 https://curecurrent.com/trials/prandial-orientated-biphasic-insulin-aspart-30-therapy-the-physiological-premix-insulin-therapy-for-type-2-diabetes-20885 https://curecurrent.com/trials/paediatric-subjects-special-survey-20886 https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-novomix-30-flexpen-20887 https://curecurrent.com/trials/special-survey-for-patients-with-type-1-or-type-2-diabetes-20888 https://curecurrent.com/trials/can-hba1c-replace-ogtt-for-the-diagnosis-of-diabetes-mellitus-among-chinese-patients-with-ifg-20889 https://curecurrent.com/trials/sensor-and-software-use-for-improved-glucose-control-in-mdi-managed-diabetes-20890 https://curecurrent.com/trials/self-control-trial-to-evaluate-the-remission-rate-in-newly-diagnosed-type-2-diabetes-patients-after-treatment-with-insul-20891 https://curecurrent.com/trials/special-survey-for-type-1-or-type-2-diabetic-patients-20892 https://curecurrent.com/trials/special-survey-for-paediatric-subjects-20893 https://curecurrent.com/trials/special-survey-of-production-of-insulin-aspart-specific-antibody-20894 https://curecurrent.com/trials/protective-effect-on-the-coronary-microcirculation-of-patients-with-diabetes-by-clopidogrel-or-ticagrelor-20895 https://curecurrent.com/trials/minimed-640g-system-user-evaluation-with-the-question-of-reducing-the-rate-of-hypoglycemia-20896 https://curecurrent.com/trials/comparison-of-basal-fasting-glycemic-control-in-type-1-diabetic-patients-with-csii-achieved-by-the-circadian-slide-ruler-20897 https://curecurrent.com/trials/a-monocenter-open-label-glucose-clamp-study-examining-the-metabolic-effect-of-insulin-infusion-intervals-for-basal-insul-20898 https://curecurrent.com/trials/clinical-study-opened-of-cutaneous-acceptability-of-a-topic-product-in-normal-conditions-of-use-20899 https://curecurrent.com/trials/observational-study-in-type-2-diabetes-treated-by-an-intensive-insulin-treatment-ict-containing-once-daily-levemir-insul-20900 https://curecurrent.com/trials/observational-study-of-patients-with-diabetes-using-levemir-flexpen-20901 https://curecurrent.com/trials/observational-study-of-the-switch-of-metformin-alone-to-metformin-combined-with-repaglinide-in-type-2-diabetes-20902 https://curecurrent.com/trials/the-impact-of-initiating-switching-to-insulin-detemir-on-emotional-well-being-and-treatment-satisfaction-20903 https://curecurrent.com/trials/safety-of-insulin-detemir-for-the-treatment-of-insulin-dependent-type-1-or-type-2-diabetes-mellitus-20904 https://curecurrent.com/trials/prisma-study-prospective-randomized-trial-on-intensive-self-monitoring-blood-glucose-management-added-value-in-non-insul-20905 https://curecurrent.com/trials/evaluation-of-the-use-of-levemir-in-insufficiently-controlled-patients-with-type-1-or-type-2-diabetes-20906 https://curecurrent.com/trials/a-study-comparing-continuous-subcutaneous-insulin-infusion-with-multiple-daily-injections-with-insulin-lispro-and-glargi-20907 https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-and-metformin-combination-therapy-in-type-2-diabetes-failing-on-oral-anti-diabetic-dr-20908 https://curecurrent.com/trials/comparison-of-the-management-of-post-prandial-hyperglycemia-by-multiple-bolus-calculators-20909 https://curecurrent.com/trials/vitamin-d-supplements-on-markers-for-cardiovascular-disease-and-diabetes-an-individual-participant-data-meta-analysis-20910 https://curecurrent.com/trials/vildagliptin-vs-sitagliptin-add-on-to-insulin-impact-on-glycemic-profile-and-correlation-of-hypoglycemic-episodes-and-he-20911 https://curecurrent.com/trials/alpha-lipoic-acid-for-treatment-of-diabetic-neuropathy-20912 https://curecurrent.com/trials/optimizing-the-beneficial-health-effects-of-exercise-for-diabetes-focus-on-the-liver-20913 https://curecurrent.com/trials/dairy-lipids-proteins-and-the-metabolic-syndrome-dairyhealth-20914 https://curecurrent.com/trials/study-of-efficacy-and-safety-of-vildagliptin-as-add-on-insulin-therapy-in-t2dm-patients-20915 https://curecurrent.com/trials/the-effect-of-different-food-products-on-post-prandial-blood-glucose-in-pregnant-woman-with-diabetes-20916 https://curecurrent.com/trials/cirrhosis-effects-of-transplantation-and-diabetes-20917 https://curecurrent.com/trials/human-faecal-microbiota-in-type-2-diabetes-20918 https://curecurrent.com/trials/safety-and-efficacy-of-low-intensity-shockwave-therapy-in-treating-diabetic-foot-ulcers-20919 https://curecurrent.com/trials/the-effect-of-pioglitazone-on-neointima-volume-and-inflammatory-markers-20920 https://curecurrent.com/trials/diabetes-specific-nutritional-formulas-versus-oatmeal-20921 https://curecurrent.com/trials/human-factors-and-home-use-study-of-the-vigilant-diabetes-management-application-20922 https://curecurrent.com/trials/relation-of-visceral-fat-and-associated-cytokines-with-early-cardiovascular-complications-in-type-1-diabetes-20923 https://curecurrent.com/trials/metabolic-signalling-in-muscle-and-adipose-tissue-following-insulin-withdrawal-and-growth-hormone-injection-20924 https://curecurrent.com/trials/effects-of-linagliptin-in-addition-to-empagliflozin-on-islet-cell-physiology-20925 https://curecurrent.com/trials/a-study-of-phyllanthus-niruri-and-sida-cordifolia-in-diabetic-peripheral-polyneuropathy-20926 https://curecurrent.com/trials/11c-5-htp-pet-in-clinical-islet-transplantation-20927 https://curecurrent.com/trials/diabetes-coaching-study-20928 https://curecurrent.com/trials/open-non-comparative-multi-centre-post-marketing-clinical-follow-up-investigation-to-evaluate-performance-and-safety-on-20929 https://curecurrent.com/trials/feel4diabetes-study-20930 https://curecurrent.com/trials/arginase-inhibition-and-microvascular-endothelial-function-in-type-2-diabetes-20931 https://curecurrent.com/trials/diabetes-in-india-nutrition-guidelines-study-dings-20932 https://curecurrent.com/trials/observational-study-of-type-1-and-type-2-diabetes-patients-having-switched-from-human-premixes-to-novomix-30-20933 https://curecurrent.com/trials/csii-in-type-1-diabetes-diet-quality-of-life-cardiometabolic-risks-a-cross-sectional-study-20934 https://curecurrent.com/trials/paclitaxel-eluting-balloon-versus-drug-eluting-stent-in-native-coronary-artery-stenoses-of-diabetic-patients-20935 https://curecurrent.com/trials/phase-1-study-to-explore-the-safety-and-pharmacokinetics-of-dapaglifozin-in-adolescents-and-adults-with-type-1-diabetes-20936 https://curecurrent.com/trials/csii-in-type-1-diabetes-diet-quality-of-life-cardiometabolic-risks-a-longitudinal-study-20937 https://curecurrent.com/trials/effects-of-chronic-dietary-exposure-to-branched-chain-amino-acids-20938 https://curecurrent.com/trials/visceral-adiposity-and-cvd-risk-in-women-20939 https://curecurrent.com/trials/hyperapo-b-and-coronary-heart-disease-20940 https://curecurrent.com/trials/serum-total-homocysteine-and-c-reactive-protein-ancillary-to-idnt-20941 https://curecurrent.com/trials/long-term-predictors-of-morbidity-in-older-age-20942 https://curecurrent.com/trials/prenatal-nutrition-and-adult-disease-20943 https://curecurrent.com/trials/cardiac-and-renal-disease-study-cards-20944 https://curecurrent.com/trials/epidemiology-of-cardiovascular-and-non-cardiovascular-risk-in-chicago-20945 https://curecurrent.com/trials/adiposity-and-fat-patterning-in-black-americans-20946 https://curecurrent.com/trials/evaluation-of-novel-risk-factors-and-clinical-outcomes-of-acute-myocardial-infarction-20947 https://curecurrent.com/trials/predisposition-genes-in-monogenic-diabetes-diamono-20948 https://curecurrent.com/trials/effects-of-sitaglpitin-on-endothelial-function-during-the-ogtt-in-t2dm-20949 https://curecurrent.com/trials/digestive-tract-reconstruction-after-gastrectomy-of-gastric-cancer-with-type-2-diabetes-20950 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk8245-8245-004-completed-20951 https://curecurrent.com/trials/effect-of-topic-pirfenidone-in-diabetic-ulcers-20952 https://curecurrent.com/trials/the-effect-of-prostaglandin-i2-on-the-endothelial-cell-function-disorder-in-type-2-diabetes-mellitus-patients-20953 https://curecurrent.com/trials/intranasal-insulin-and-its-effect-on-postprandial-metabolism-in-comparison-to-subcutaneous-insulin-20954 https://curecurrent.com/trials/assessment-of-the-neurovascular-microcirculatory-response-in-diabetes-type-1-patients-20955 https://curecurrent.com/trials/efficacy-of-sasi-bypass-for-type-2-diabetic-obese-patients-20956 https://curecurrent.com/trials/prevalence-of-unknown-and-known-diabetes-in-patients-with-frozen-shoulder-20957 https://curecurrent.com/trials/genetics-of-the-metabolic-syndrome-in-japanese-americans-20958 https://curecurrent.com/trials/endobarrier-sans-in-over-weight-or-obese-type-2-diabetic-subjects-20959 https://curecurrent.com/trials/central-obesity-and-disease-risk-in-japanese-americans-20960 https://curecurrent.com/trials/multiple-dose-trial-of-anti-glycation-agent-gly-230-in-healthy-and-diabetic-subjects-20961 https://curecurrent.com/trials/nutritional-therapy-and-education-with-multimedia-application-in-patients-with-type-2-diabetes-20962 https://curecurrent.com/trials/comparison-of-insulin-detemir-produced-by-the-current-process-and-the-nn729-process-in-healthy-subjects-20963 https://curecurrent.com/trials/enhancing-support-for-women-at-risk-for-heart-disease-20964 https://curecurrent.com/trials/lifestyle-management-for-women-with-chd-and-niddm-20965 https://curecurrent.com/trials/investigate-the-effect-of-food-on-the-pharmacokinetic-characteristics-of-ckd-395-in-healthy-male-volunteers-20966 https://curecurrent.com/trials/wisconsin-epidemiological-study-of-cardiovascular-disease-in-type-1-diabetes-20967 https://curecurrent.com/trials/bypass-angioplasty-revascularization-investigation-in-type-2-diabetes-20968 https://curecurrent.com/trials/multi-ethnic-study-of-atherosclerosis-mesa-ancillary-eye-study-20969 https://curecurrent.com/trials/a-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk-5823-in-overweight-or-obese-participants-20970 https://curecurrent.com/trials/a-study-to-test-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk1006-mk-1006-002-completed-20971 https://curecurrent.com/trials/januvia-re-examination-study-mk-0431-181-20972 https://curecurrent.com/trials/physician-led-counseling-in-management-of-depression-in-type-2-diabetes-mellitus-20973 https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-mk8245-in-patients-with-type-2-diabetes-mellitus-and-inadequate-glycemic-co-20974 https://curecurrent.com/trials/a-study-of-sitagliptin-in-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control-on-diet-exercise-t-20975 https://curecurrent.com/trials/pioglitazone-add-on-study-in-patients-with-type-2-diabetes-mellitus-20976 https://curecurrent.com/trials/a-multiple-dose-study-of-mk-1006-mk-1006-004-terminated-20977 https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-two-formulations-of-mk-1006-mk-1006-010-am1-completed-20978 https://curecurrent.com/trials/nutritional-intervention-of-type-ii-diabetes-mellitus-by-vitamin-d-in-qatar-20979 https://curecurrent.com/trials/the-reduced-insulinotropic-effect-of-a-continuous-infusion-relative-to-a-bolus-injection-of-gip-20980 https://curecurrent.com/trials/single-doses-of-mk-0941-in-type-2-diabetics-mk-0941-027-20981 https://curecurrent.com/trials/comparative-study-of-insulin-therapy-between-inner-and-outer-upper-thigh-20982 https://curecurrent.com/trials/integrated-diabetes-management-protocol-using-smartphone-20983 https://curecurrent.com/trials/safety-and-exploratory-efficacy-study-of-collagen-membrane-with-mesenchymal-stem-cells-in-the-treatment-of-skin-defects-20984 https://curecurrent.com/trials/atorvastatin-versus-vitamin-e-in-treatment-of-non-alcoholic-fatty-liver-disease-20985 https://curecurrent.com/trials/liquid-protein-preloads-with-different-carbohydrate-types-effects-on-the-glycaemic-and-insulinaemic-response-20986 https://curecurrent.com/trials/studying-the-effect-of-capsinoids-on-brown-fat-using-infrared-thermal-imaging-20987 https://curecurrent.com/trials/incretin-based-therapy-for-poorly-controlled-type-2-diabetic-patients-20988 https://curecurrent.com/trials/a-24-week-multicenter-prospective-open-labeled-single-arm-exploratory-phase-4-clinical-trial-to-evaluate-the-safety-and-20989 https://curecurrent.com/trials/the-efficacy-and-safety-study-in-patients-with-type-2-diabetes-mellitus-20990 https://curecurrent.com/trials/study-to-determine-ethnic-differences-in-the-glycaemic-response-to-nutritional-formula-drinks-20991 https://curecurrent.com/trials/comparison-between-losartan-and-benazepril-in-diabetic-hypertensive-patients-not-controlled-by-amlodipine-20992 https://curecurrent.com/trials/risk-factors-for-atherogenesis-in-type-1-diabetes-20993 https://curecurrent.com/trials/fgf-21-and-exercise-in-relation-to-insulin-secretion-20994 https://curecurrent.com/trials/effects-of-rosiglitazone-on-inflammatory-markers-and-adipokines-in-diabetic-patients-using-an-angiotensin-receptor-block-20995 https://curecurrent.com/trials/system-accuracy-evaluation-of-karajishi-contour-and-karajishi-ts-blood-glucose-monitoring-systems-following-iso-15197-20-20996 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-musashino-diabetes-diet-in-type-ii-diabetes-mellitus-disease-20997 https://curecurrent.com/trials/efficacy-safety-study-of-glimepiride-to-type-2-diabetes-patients-based-on-metformin-and-basal-insulin-treatment-20998 https://curecurrent.com/trials/evaluation-of-novel-trend-arrow-adjustment-tool-for-diabetes-patients-using-continuous-glucose-monitoring-to-guide-insul-20999 https://curecurrent.com/trials/effects-of-ginger-supplementation-on-nf-kb-in-peripheral-blood-mononuclear-cells-in-type-2-diabetes-mellitus-21000 https://curecurrent.com/trials/long-term-effects-of-transcranial-direct-current-stimulation-tdcs-on-patients-with-phantom-limb-pain-plp-21001 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-rising-doses-of-bi-187004-in-patients-with-type-2-21002 https://curecurrent.com/trials/safety-study-of-stem-cells-treatment-in-diabetic-foot-ulcers-21003 https://curecurrent.com/trials/evaluation-of-pressure-distribution-of-kyboot-shoes-in-comparison-to-other-foot-wear-21004 https://curecurrent.com/trials/diabetes-outcomes-and-nurse-case-manager-study-21005 https://curecurrent.com/trials/liraglutide-in-type-1-diabetes-21006 https://curecurrent.com/trials/polyethylene-glycol-loxenatide-pharmacokinetics-study-in-subjects-with-normal-and-insufficiency-renal-function-21007 https://curecurrent.com/trials/user-performance-evaluation-of-contour-plus-accu-chek-active-accu-chek-performa-and-onetouch-select-simple-blood-glucose-21008 https://curecurrent.com/trials/effects-of-pancreaticoduodenectomy-on-glucose-metabolism-21009 https://curecurrent.com/trials/metformin-in-obese-non-diabetic-pregnant-women-21010 https://curecurrent.com/trials/gather-mhealth-india-rct-for-behavior-and-health-outcomes-21011 https://curecurrent.com/trials/precise-a-prospective-multi-center-evaluation-of-the-accuracy-of-a-novel-continuous-implanted-glucose-sensor-21012 https://curecurrent.com/trials/study-of-liraglutide-in-individuals-with-type-2-diabetes-using-insulin-21013 https://curecurrent.com/trials/diabetes-screening-prevention-for-people-with-learning-intellectual-disabilities-stop-diabetes-study-21014 https://curecurrent.com/trials/nitric-oxide-generating-gel-dressing-in-patients-with-diabetic-foot-ulcers-21015 https://curecurrent.com/trials/gut-hormone-profiling-in-obese-patients-with-type-2-diabetes-mk-0000-134-21016 https://curecurrent.com/trials/surrogate-markers-for-sudden-cardiac-death-in-patients-with-diabetes-mellitus-and-end-stage-renal-disease-21017 https://curecurrent.com/trials/less-neuropathy-after-yoga-managing-diabetic-neuropathy-with-yoga-21018 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-and-pharmacodynamic-characteristics-of-explorative-formulations-of-insulin-deglu-21019 https://curecurrent.com/trials/a-role-for-brown-adipose-tissue-in-postprandial-thermogenesis-21020 https://curecurrent.com/trials/beneficial-effect-of-xylose-consumption-on-postprandial-hyperglycemia-21021 https://curecurrent.com/trials/ex-vivo-immunotherapy-for-hyperglycemia-in-type-2-diabetes-mellitus-21022 https://curecurrent.com/trials/effects-of-personalized-dietary-advice-on-health-status-of-diabetes-type-2-patients-21023 https://curecurrent.com/trials/trial-to-assess-the-efficacy-of-neuroprotective-drugs-administered-topically-to-prevent-or-arrest-diabetic-retinopathy-21024 https://curecurrent.com/trials/combined-vasopressin-methylprednisolone-and-epinephrine-for-inhospital-cardiac-arrest-21025 https://curecurrent.com/trials/0-3-sodium-hyaluronate-in-the-treatment-of-dry-eye-of-diabetic-patients-21026 https://curecurrent.com/trials/physical-activity-hypertension-diabetes-and-coronary-heart-disease-21027 https://curecurrent.com/trials/education-effectiveness-for-type-1-diabetes-mellitus-on-insulin-pump-therapy-21028 https://curecurrent.com/trials/albiglutide-versus-placebo-added-on-to-basal-bolus-insulin-therapy-in-subjects-with-type-2-diabetes-mellitus-21029 https://curecurrent.com/trials/feasibility-of-using-a-smart-phone-application-for-self-titration-of-insulin-on-glycemic-control-in-patients-with-t2dm-21030 https://curecurrent.com/trials/effects-of-glp-1-on-chronic-heart-failure-21031 https://curecurrent.com/trials/purified-anthocyanins-supplementation-and-high-density-lipoprotein-hdl-function-21032 https://curecurrent.com/trials/screening-for-liver-fibrosis-by-using-non-invasive-methods-in-patients-with-diabetes-a-prospective-study-21033 https://curecurrent.com/trials/towards-simple-and-non-invasive-assessment-of-residual-beta-cell-function-in-type-1-diabetes-21034 https://curecurrent.com/trials/mk-1006-single-dose-study-in-japanese-type-2-diabetes-patients-mk-1006-005-21035 https://curecurrent.com/trials/a-clinical-study-to-compare-the-pharmacokinetic-characteristics-of-ckd-395-0-25-750-mg-in-healthy-male-volunteers-21036 https://curecurrent.com/trials/the-effect-of-90-day-oral-testosterone-therapy-in-chinese-males-with-type-2-diabetes-t2dm-21037 https://curecurrent.com/trials/an-efficacy-and-safety-study-of-beloranib-in-obese-subjects-with-type-2-diabetes-mellitus-21038 https://curecurrent.com/trials/intravitreal-ranibizumab-injection-as-adjuvant-in-the-treatment-of-postvitrectomy-diabetic-vitreous-hemorrhage-accompani-21039 https://curecurrent.com/trials/effect-of-sleep-apnea-treatment-on-type-1-diabetes-21040 https://curecurrent.com/trials/effect-of-preoperative-topical-ketorolac-on-aqueous-cytokine-levels-and-macular-thickness-in-cataract-surgery-patients-21041 https://curecurrent.com/trials/glycemic-responses-and-of-the-autonomic-cardiac-function-in-diabetes-type-2-women-post-resistance-exercise-21042 https://curecurrent.com/trials/the-effect-of-melatonin-on-early-signs-of-hypertension-in-teenagers-with-diabetes-mellitus-type-1-21043 https://curecurrent.com/trials/pascal-laser-platform-produces-less-pain-responses-compared-to-conventional-laser-system-21044 https://curecurrent.com/trials/clinical-and-microbiological-evaluation-of-periodontal-treatment-of-diabetic-patients-a-longitudinal-study-21045 https://curecurrent.com/trials/use-of-mobile-technology-to-promote-sustained-lifestyle-changes-to-prevent-type-2-diabetes-in-india-and-the-uk-21046 https://curecurrent.com/trials/sitagliptin-in-prevention-of-type-2-diabetes-mellitus-21047 https://curecurrent.com/trials/salt-sensitivity-cardiovascular-and-metabolic-disease-21048 https://curecurrent.com/trials/clinical-trial-for-liquid-food-inslow-21049 https://curecurrent.com/trials/governance-of-diabetes-management-in-non-specialistic-hospital-settings-21050 https://curecurrent.com/trials/medico-gdm-trial-metformine-to-prevent-gestational-diabetes-mellitus-21051 https://curecurrent.com/trials/pharmacokinetic-pk-bioequivalence-and-pharmacodynamics-of-julphar-insulin-r-and-huminsulin-normal-21052 https://curecurrent.com/trials/efficacy-study-of-izn-6d4-gel-for-the-treatment-of-diabetic-foot-ulcers-21053 https://curecurrent.com/trials/incentives-for-internet-based-adherence-to-smbg-for-teens-with-t1d-21054 https://curecurrent.com/trials/proof-of-concept-design-validation-in-patient-with-hard-to-heal-wounds-such-as-pressure-ulcer-diabetic-foot-ulcer-and-le-21055 https://curecurrent.com/trials/aerobic-training-in-pregnant-women-with-gestational-diabetes-and-chronic-hypertension-21056 https://curecurrent.com/trials/effect-of-personalized-feedback-report-and-peer-support-on-diabetes-21057 https://curecurrent.com/trials/the-long-term-effect-of-adjustable-spaatz-3-intragastric-balloon-on-weight-loss-21058 https://curecurrent.com/trials/graz-study-on-the-risk-of-atrial-fibrillation-21059 https://curecurrent.com/trials/quantification-of-the-dipeptidyl-peptidase-dpp-4-inhibition-mediated-enhancement-of-the-activity-of-the-entero-insular-a-21060 https://curecurrent.com/trials/improving-the-quality-of-patient-care-by-using-a-clinical-expert-system-21061 https://curecurrent.com/trials/pizza-salami-study-in-children-and-adolescents-with-type-1-diabetes-21062 https://curecurrent.com/trials/a-study-to-test-mk-0941-in-patients-with-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-metformin-mk-0941-21063 https://curecurrent.com/trials/impact-of-a-diabetes-camp-on-glycemic-control-among-children-and-adolescents-living-with-type-1-diabetes-in-cameroon-21064 https://curecurrent.com/trials/efficacy-of-pirfenidone-plus-modd-in-diabetic-foot-ulcers-21065 https://curecurrent.com/trials/low-glycemic-index-diets-vs-high-cereal-fibre-diets-in-type-2-diabetes-21066 https://curecurrent.com/trials/periodontal-treatment-in-non-controlled-type-2-diabetes-mellitus-patients-clinical-trial-21067 https://curecurrent.com/trials/effect-of-the-dpp-4-inhibitor-sitagliptin-on-islet-function-after-mixed-meal-in-patients-with-type-2-diabetes-21068 https://curecurrent.com/trials/study-on-lixisenatide-and-counterregulation-to-hypoglycemia-21069 https://curecurrent.com/trials/effects-of-adjunct-photodynamic-therapy-in-the-treatment-of-type-2-diabetic-patients-with-chronic-periodontitis-21070 https://curecurrent.com/trials/pharmacokinetics-study-of-dipeptidyl-peptidase-4-inhibitor-to-control-type-2-diabetes-mellitus-21071 https://curecurrent.com/trials/peripheral-insulin-uptake-in-type-2-diabetes-mellitus-and-in-non-diabetic-individuals-21072 https://curecurrent.com/trials/safeguard-pleiotropic-effects-of-incretin-based-therapies-21073 https://curecurrent.com/trials/insulin-therapy-for-post-transplant-glucocorticoid-induced-hyperglycemia-21074 https://curecurrent.com/trials/liraglutide-use-in-prader-willi-syndrome-21075 https://curecurrent.com/trials/fruits-vegetables-and-whole-grains-a-community-based-intervention-21076 https://curecurrent.com/trials/effects-of-exenatide-in-type-2-diabetic-patients-with-congestive-heart-failure-21077 https://curecurrent.com/trials/low-glycemic-index-diet-with-canola-oil-for-type-2-diabetics-21078 https://curecurrent.com/trials/low-glycemic-index-diets-with-pulses-in-type-2-diabetes-21079 https://curecurrent.com/trials/effect-of-bariatric-surgery-on-gut-hormones-production-and-cure-of-type-2-diabetes-mellitus-21080 https://curecurrent.com/trials/educational-efficacy-assessment-of-a-serious-game-to-teach-insulin-therapy-to-primary-care-physicians-21081 https://curecurrent.com/trials/the-effect-of-a-gastric-bypass-on-type-2-diabetes-in-the-morbidly-obese-patient-21082 https://curecurrent.com/trials/utilization-of-platelet-gel-for-treatment-of-diabetic-foot-ulcers-21083 https://curecurrent.com/trials/improving-glycaemic-control-with-l-carnitine-21084 https://curecurrent.com/trials/insulin-sensitivity-of-the-human-cns-system-fmri-study-with-intranasal-insulin-application-21085 https://curecurrent.com/trials/effects-of-low-power-laser-therapy-on-muscle-performance-isokinetic-pre-exercise-in-individuals-with-diabetes-mellitus-t-21086 https://curecurrent.com/trials/retinal-ganglion-cell-complex-changes-by-optical-coherence-tomography-in-diabetic-patients-without-retinopathy-21087 https://curecurrent.com/trials/web-based-support-for-people-with-type-2-diabetes-21088 https://curecurrent.com/trials/regulation-of-endogenous-glucose-production-by-brain-insulin-action-21089 https://curecurrent.com/trials/rct-evaluating-effects-of-cosmos-caudatus-ulam-raja-in-t2dm-patients-21090 https://curecurrent.com/trials/efficacy-and-safety-of-smoking-cessation-with-varenicline-tartrate-in-diabetic-smokers-diasmoke-21091 https://curecurrent.com/trials/hyperbaric-oxygen-therapy-and-insulin-resistance-hotair2-effect-of-one-hbo-session-21092 https://curecurrent.com/trials/the-effect-of-aquacel-ag-extra-dressing-on-wound-biofilms-21093 https://curecurrent.com/trials/hypertension-and-diabetes-initiative-improving-hypertension-control-in-individuals-with-diabetes-21094 https://curecurrent.com/trials/a-study-of-intracellular-signaling-in-muscle-and-fat-cells-during-ketosis-21095 https://curecurrent.com/trials/study-of-circadian-clock-properties-in-healthy-subjects-obese-and-type-2-diabetic-patients-21096 https://curecurrent.com/trials/eradication-of-gut-microbiota-21097 https://curecurrent.com/trials/acute-regulation-of-intestinal-and-hepatic-lipoprotein-production-by-glucagon-21098 https://curecurrent.com/trials/a-trial-to-compare-the-pharmacodynamic-and-pharmacokinetic-properties-of-biochaperone-combo-with-humalog-mix25-and-with-21099 https://curecurrent.com/trials/involvement-of-extrapancreatic-factors-on-gastrointestinal-mediated-glucose-disposal-21100 https://curecurrent.com/trials/endogenous-glucoseproduction-in-patients-with-type-2-diabetes-mellitus-during-oral-glucose-and-iv-glucose-infusion-21101 https://curecurrent.com/trials/effects-of-tianqi-capsule-on-glucose-variability-in-patients-with-type-2-diabetes-21102 https://curecurrent.com/trials/effectiveness-and-cost-effectiveness-of-the-diabetes-integrated-care-breakthrough-collaborative-21103 https://curecurrent.com/trials/development-of-rational-ways-of-medical-and-non-medical-treatment-methods-for-metabolic-syndrome-21104 https://curecurrent.com/trials/effects-of-standing-and-light-intensity-activity-on-ambulatory-blood-pressure-and-blood-glucose-21105 https://curecurrent.com/trials/inulin-scfa-production-and-metabolic-response-21106 https://curecurrent.com/trials/spectral-domain-optical-coherence-tomography-of-the-eye-21107 https://curecurrent.com/trials/the-drug-drug-interaction-of-shr3824-and-sp2086-21108 https://curecurrent.com/trials/statin-lowering-testosterone-and-sexual-function-21109 https://curecurrent.com/trials/comparative-study-of-antibacterial-effect-on-silver-dressing-of-negative-pressure-wound-21110 https://curecurrent.com/trials/a-clinical-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-oral-zygk1-in-healthy-volunteers-21111 https://curecurrent.com/trials/effect-of-bile-acid-sequestration-on-postprandial-glp-1-secretion-glucose-homeostasis-and-gut-microbiota-21112 https://curecurrent.com/trials/effect-of-smartphone-app-on-activity-21113 https://curecurrent.com/trials/obesity-and-metabolic-surgery-in-patients-with-type-i-diabetes-21114 https://curecurrent.com/trials/obliterating-diabetic-microangiopathy-of-the-diabetic-foot-21115 https://curecurrent.com/trials/effects-of-vildagliptine-and-glimepiride-on-glucose-variability-21116 https://curecurrent.com/trials/effect-of-islet-autotransplantation-compared-to-oral-antidiabetic-drug-21117 https://curecurrent.com/trials/using-combined-instantaneous-and-multidimensional-feedback-to-support-a-change-in-physical-activity-behaviour-21118 https://curecurrent.com/trials/pioglitazone-versus-metformin-in-type-2-diabetes-21119 https://curecurrent.com/trials/25gr-glucomedics-vs-25gr-zusto-21120 https://curecurrent.com/trials/sitagliptin-dpp-4-inhibitor-and-nph-insulin-in-patients-with-t2d-21121 https://curecurrent.com/trials/safety-and-efficacy-of-acarbose-saxagliptin-compared-with-metformin-saxagliptin-in-patients-with-type-2-diabetes-21122 https://curecurrent.com/trials/the-effect-of-n-3-fatty-acid-supplementation-on-serum-levels-and-gene-expression-of-type2-diabetes-patient-21123 https://curecurrent.com/trials/the-effect-of-online-based-mentoring-program-on-the-blood-glucose-and-satisfaction-score-in-type-1-diabetes-patients-21124 https://curecurrent.com/trials/evaluation-of-diabetic-effects-on-clinical-outcomes-after-sirolimus-eluting-stents-in-the-asian-population-21125 https://curecurrent.com/trials/improving-postprandial-glycaemia-by-a-new-developed-closed-loop-control-system-closedloop4meals-21126 https://curecurrent.com/trials/effects-of-various-bariatric-surgical-procedures-on-intestinal-trl-metabolism-in-obese-type-2-diabetic-patients-21127 https://curecurrent.com/trials/the-balance-control-mechanism-of-dpn-patients-21128 https://curecurrent.com/trials/a-clinical-trial-analyzing-effects-of-prokinetic-drug-on-the-blood-glucose-in-patients-with-type-2-diabetes-21129 https://curecurrent.com/trials/efficacy-and-safety-of-resolute-zotarolimus-eluting-stent-in-treatment-of-chinese-diabetic-coronary-lesions-21130 https://curecurrent.com/trials/purified-anthocyanins-supplementation-in-type-2-diabetes-mellitus-21131 https://curecurrent.com/trials/phase-2-study-of-ngm282-in-patients-with-type-2-diabetes-21132 https://curecurrent.com/trials/acupuncture-in-the-complementary-treatment-of-diabetes-mellitus-type-ii-21133 https://curecurrent.com/trials/closed-loop-control-of-postprandial-glucose-levels-in-adults-with-type-1-diabetes-21134 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-daily-oral-tak-875-25-and-50mg-in-asia-pacific-adults-with-type-2-diabetes-21135 https://curecurrent.com/trials/measurement-of-the-pancreas-function-in-patients-with-more-than-one-pancreas-after-liver-and-small-bowel-transplantation-21136 https://curecurrent.com/trials/elevated-circulating-ffa-and-intrahepatic-lipid-content-21137 https://curecurrent.com/trials/metabolic-complications-following-knee-injury-in-young-and-middle-aged-patients-21138 https://curecurrent.com/trials/benefit-of-iqp-vv-102-in-reducing-postprandial-glucose-level-in-overweight-caucasian-subjects-21139 https://curecurrent.com/trials/the-effect-of-hypoglycaemia-on-brain-lactate-accumulation-and-cerebral-blood-flow-21140 https://curecurrent.com/trials/can-topical-oxygen-therapy-natrox-improve-wound-healing-in-diabetic-foot-ulcers-21141 https://curecurrent.com/trials/meta-analyses-of-the-effect-of-legumes-on-blood-pressure-21142 https://curecurrent.com/trials/a-series-of-systematic-reviews-and-meta-analyses-of-the-effect-of-vegetarian-vegan-diets-on-cardiometabolic-risk-21143 https://curecurrent.com/trials/system-accuracy-evaluation-of-6-ce-marked-blood-glucose-monitoring-system-following-iso-15197-2013-21144 https://curecurrent.com/trials/effect-of-macronutrient-supplementation-on-glycemic-index-of-pita-bread-21145 https://curecurrent.com/trials/effect-of-exercise-frequency-on-metabolic-control-and-heart-function-in-type-2-diabetes-21146 https://curecurrent.com/trials/postprandial-blood-glucose-control-with-biochaperone-combo-and-insulin-lispro-humalog-mix-25-in-people-with-type-1-diabe-21147 https://curecurrent.com/trials/hybrid-artificial-pancreas-in-home-setting-21148 https://curecurrent.com/trials/efficacy-and-safety-of-lidocaine-infusion-treatment-in-management-of-neuropathic-pain-21149 https://curecurrent.com/trials/norvit-and-wenbit-long-term-follow-up-21150 https://curecurrent.com/trials/pharmaceutical-care-program-for-type-2-diabetes-mellitus-21151 https://curecurrent.com/trials/chemerin-and-il-6-levels-in-diabetes-and-periodontitis-21152 https://curecurrent.com/trials/gingival-crevicular-fluid-vaspin-and-omentin-levels-in-type-2-diabetic-patients-with-chronic-periodontitis-21153 https://curecurrent.com/trials/implementing-online-patient-provider-communication-into-clinical-practice-21154 https://curecurrent.com/trials/acupuncture-for-diabetic-gastroparalysis-a-randomized-controlled-trial-21155 https://curecurrent.com/trials/pharmacokinetics-study-of-gamma-aminobutyric-acid-21156 https://curecurrent.com/trials/long-term-excess-mortality-of-acute-myocardial-infarction-in-patients-with-and-without-diabetes-a-population-based-cohor-21157 https://curecurrent.com/trials/the-features-behind-the-beneficial-effects-of-interval-walking-21158 https://curecurrent.com/trials/drug-trial-of-lixisenatide-on-gastric-emptying-and-blood-pressure-drops-in-type-2-diabetics-and-healthy-people-21159 https://curecurrent.com/trials/effects-of-sitagliptin-on-gastric-emptying-in-healthy-subjects-21160 https://curecurrent.com/trials/comparison-of-vildagliptin-vs-glimepiride-on-glucose-variability-in-metformin-uncontrolled-type-2-diabetic-patients-21161 https://curecurrent.com/trials/reliability-of-insulin-by-jet-injection-21162 https://curecurrent.com/trials/life-long-monitoring-of-diabetes-mellitus-in-veneto-region-21163 https://curecurrent.com/trials/life-long-monitoring-of-frail-patients-with-chronic-diseases-21164 https://curecurrent.com/trials/effect-of-smart-phone-application-on-the-individualized-management-of-chinese-diabetic-patients-21165 https://curecurrent.com/trials/blood-sugar-responses-by-physical-activity-level-and-intensity-21166 https://curecurrent.com/trials/bone-marrow-derived-stem-cell-transplantation-in-t2dm-21167 https://curecurrent.com/trials/efficacy-and-safety-of-voice-inception-technique-based-u-healthcare-service-in-patients-with-type-2-diabetes-mellitus-21168 https://curecurrent.com/trials/the-usefulness-of-postprandial-triglyceride-for-assessment-of-cardiovascular-risk-21169 https://curecurrent.com/trials/comparison-of-diabetes-retinopathy-among-type-2-diabetic-patients-treated-with-different-regimens-21170 https://curecurrent.com/trials/association-of-kisspeptin-levels-with-insulin-secretion-in-diabetes-mellitus-21171 https://curecurrent.com/trials/a-one-year-randomized-controlled-trial-evaluating-the-impact-of-pioglitazone-versus-linagliptin-on-bone-turnover-markers-21172 https://curecurrent.com/trials/bioequivalence-between-two-explorative-insulin-degludec-formulations-and-between-two-explorative-idegasp-formulations-in-21173 https://curecurrent.com/trials/association-of-agtr1-and-acacb-gene-polymorphism-and-diabetic-nephropathy-in-type-2-diabetes-21174 https://curecurrent.com/trials/comparison-of-thrice-daily-biphasic-human-insulin-with-basal-bolus-regimen-in-type-2-diabetes-mellitus-patients-21175 https://curecurrent.com/trials/oral-cholecalciferol-in-prevention-of-type-2-diabetes-mellitus-21176 https://curecurrent.com/trials/efficacy-of-laparoscopic-sleeve-gastrectomy-and-intensive-medical-management-in-obese-type-2-diabetes-21177 https://curecurrent.com/trials/tissue-distribution-of-f18-fdg-labeled-abmsct-in-patients-with-type2-diabetes-mellitus-21178 https://curecurrent.com/trials/comparison-of-explorative-formulation-of-insulin-degludec-and-insulin-aspart-co-formulation-versus-explorative-formulati-21179 https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-explorative-formulation-of-insulin-degludec-21180 https://curecurrent.com/trials/comparison-of-idegasp-inclusive-three-explorative-formulations-with-insulin-degludec-and-insulin-aspart-separately-injec-21181 https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-two-idegasp-one-explorative-preparations-and-two-insulin-degludec-one-ex-21182 https://curecurrent.com/trials/efficacy-study-of-ultrasound-assisted-debridement-to-influence-wound-healing-21183 https://curecurrent.com/trials/the-effect-of-glp-1-on-postprandial-glucagon-secretion-independent-of-the-gastric-emptying-rate-21184 https://curecurrent.com/trials/treatment-of-prp-on-diabetes-wound-21185 https://curecurrent.com/trials/renin-and-aldosterone-levels-in-the-preterm-neonate-at-risk-for-hypertension-21186 https://curecurrent.com/trials/evaluate-the-effect-of-saxagliptin-on-gut-microbiota-in-patients-with-newly-diagnosed-type-2-diabetes-21187 https://curecurrent.com/trials/investigation-of-pharmacodynamic-characteristics-of-explorative-formulation-of-insulin-degludec-in-male-subjects-with-ty-21188 https://curecurrent.com/trials/efficacy-of-autologous-bone-marrow-derived-stem-cell-transplantation-in-patients-with-type-2-diabetes-mellitus-2-21189 https://curecurrent.com/trials/efficacy-of-autologous-bone-marrow-derived-stem-cell-transplantation-in-patients-with-type-2-diabetes-mellitus-21190 https://curecurrent.com/trials/antipsychotics-and-risk-of-hyperglycemic-emergencies-21191 https://curecurrent.com/trials/evaluation-of-the-effect-of-pramlintide-on-satiety-and-food-intake-21192 https://curecurrent.com/trials/comparing-the-pharmacodynamics-and-pharmacokinetics-of-explorative-formulation-of-insulin-degludec-with-insulin-glargine-21193 https://curecurrent.com/trials/urine-plasminogen-as-a-predictor-for-development-of-preeclampsia-in-pregnant-women-with-type-1-diabetes-mellitus-21194 https://curecurrent.com/trials/a-comparison-of-european-and-chinese-blood-sugar-responses-21195 https://curecurrent.com/trials/safety-of-allo-asc-dfu-in-the-patients-with-diabetic-foot-ulcers-21196 https://curecurrent.com/trials/25-hydroxyvitamin-d-and-fatigue-the-vitality-study-21197 https://curecurrent.com/trials/the-survey-of-ipragliflozin-treatment-in-elderly-type2-diabetes-patients-21198 https://curecurrent.com/trials/e4e-health-professional-education-for-improving-care-for-canadian-aboriginal-populations-21199 https://curecurrent.com/trials/the-impact-of-resistance-training-on-type-2-diabetes-patients-21200 https://curecurrent.com/trials/dancefit-prime-a-dance-based-physical-activity-and-nutritional-intervention-for-primary-care-a-feasibility-study-21201 https://curecurrent.com/trials/coronary-blood-flow-regulation-during-general-anesthesia-21202 https://curecurrent.com/trials/the-effect-of-liraglutide-on-left-ventricular-function-in-chronic-heart-failure-patients-with-and-without-type-2-diabete-21203 https://curecurrent.com/trials/effects-of-triacylglycerol-structure-on-gut-hormones-and-haemostatic-markers-21204 https://curecurrent.com/trials/extended-niacin-laropiprant-in-patients-with-type-2-diabetes-0524a-069-21205 https://curecurrent.com/trials/platelet-dependent-thrombosis-a-placebo-controlled-trial-of-antiplatelet-therapy-clopidogrel-21206 https://curecurrent.com/trials/proof-of-confidence-study-of-ccr2-antagonist-bms-741672-in-insulin-resistance-21207 https://curecurrent.com/trials/to-assess-the-accuracy-of-the-ezscan-study-in-the-screening-for-diabetic-nephropathy-21208 https://curecurrent.com/trials/assessment-of-thrombogenicity-in-acute-coronary-syndrome-21209 https://curecurrent.com/trials/phenotypes-of-nonproliferative-diabetic-retinopathy-in-dm-2-patients-identified-by-oct-cfp-rla-and-mferg-diamarker-21210 https://curecurrent.com/trials/haptoglobin-and-diabetes-complications-in-pregnancy-21211 https://curecurrent.com/trials/tweesteden-mild-stenosis-study-21212 https://curecurrent.com/trials/community-health-workers-in-diabetes-care-in-american-samoa-21213 https://curecurrent.com/trials/intraportal-or-intramuscular-site-for-islets-in-simultaneous-islet-and-kidney-transplantation-21214 https://curecurrent.com/trials/teneligliptin-mp-513-vs-placebo-in-patient-with-metformin-monotherapy-21215 https://curecurrent.com/trials/20-years-results-by-hbp-and-dbp-in-patients-with-type-2-diabetes-mellitus-after-following-up-21216 https://curecurrent.com/trials/safety-and-tolerability-of-insulin-degludec-liraglutide-a3-in-healthy-subjects-21217 https://curecurrent.com/trials/algorithm-to-control-postprandial-post-exercise-and-night-glucose-excursions-in-a-portable-closed-loop-format-21218 https://curecurrent.com/trials/a-clinical-study-to-compare-the-pharmacokinetic-characteristics-of-ckd-395-0-5-1000-mg-in-healthy-male-volunteers-21219 https://curecurrent.com/trials/integrated-clinical-evaluation-of-traditional-chinese-medicine-tcm-and-conventional-medicine-on-diabetic-patients-21220 https://curecurrent.com/trials/effect-of-resistance-training-on-metabolic-control-and-outcome-in-prediabetes-nmr-based-metabonomics-21221 https://curecurrent.com/trials/p53-gene-therapy-in-treatment-of-diabetes-concurrent-with-hepatocellular-carcinoma-21222 https://curecurrent.com/trials/a-study-of-ly2189265-in-japanese-patients-with-type-2-diabetes-21223 https://curecurrent.com/trials/comparison-of-insulin-degludec-with-insulin-glargine-in-subjects-with-type-1-diabetes-mellitus-21224 https://curecurrent.com/trials/effects-of-pomegranate-juice-on-oxidative-stress-in-patients-with-type2-diabetes-21225 https://curecurrent.com/trials/soccer-and-health-diet-and-exercise-on-type-2-diabetes-mellitus-21226 https://curecurrent.com/trials/medium-term-health-coaching-and-life-long-monitoring-in-diabetes-mellitus-21227 https://curecurrent.com/trials/meta-analyses-of-dietary-pulses-and-cardiometabolic-risk-21228 https://curecurrent.com/trials/plant-based-ingredient-on-post-prandial-glucose-in-type-ii-diabetes-21229 https://curecurrent.com/trials/vitamin-d-for-the-prevention-of-diabetes-type-2-21230 https://curecurrent.com/trials/maternal-thyroid-function-in-early-pregnancy-and-their-relationship-with-gestational-diabetes-mellitus-21231 https://curecurrent.com/trials/dose-ranging-study-to-evaluate-the-effectiveness-and-tolerability-of-mk0736-in-patients-with-type-2-diabetes-mellitus-t2-21232 https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-glucose-tolerance-in-subjects-at-risk-for-diabetes-with-low-vitamin-d-21233 https://curecurrent.com/trials/effect-of-diacerein-in-the-metabolic-control-of-patients-with-dm-type-2-and-secondary-failure-to-metformin-21234 https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-study-of-mt-3995-at-a-low-dose-in-subjects-with-diabetic-nephropathy-21235 https://curecurrent.com/trials/model-driven-diabetes-care-21236 https://curecurrent.com/trials/the-effect-of-walking-meditation-training-on-glycemic-control-and-vascular-function-in-patients-with-type-2-diabetes-21237 https://curecurrent.com/trials/short-chain-fatty-acid-metabolism-and-energy-metabolism-21238 https://curecurrent.com/trials/glucose-in-dialysis-water-in-diabetics-with-chronic-renal-failure-21239 https://curecurrent.com/trials/exenatide-versus-glimepiride-in-patients-with-type-2-diabetes-21240 https://curecurrent.com/trials/differences-in-endothelial-function-amongst-sitagliptin-and-liraglutide-users-21241 https://curecurrent.com/trials/community-based-sport-programme-and-type-2-diabetes-21242 https://curecurrent.com/trials/corneal-changes-in-diabetics-after-phacoemulsification-21243 https://curecurrent.com/trials/evaluation-of-the-metformin-effect-on-methylglyoxal-in-patients-with-type-2-diabetes-21244 https://curecurrent.com/trials/moca-test-for-the-early-detection-of-mild-cognitive-impairment-during-annual-assessment-of-young-adults-with-diabetes-an-21245 https://curecurrent.com/trials/guided-self-determination-promoting-self-management-in-type-1-diabetes-21246 https://curecurrent.com/trials/serial-vasopressin-and-copeptin-levels-in-children-with-sepsis-and-septic-shock-21247 https://curecurrent.com/trials/walking-away-structured-education-versus-written-information-for-individuals-with-high-risk-of-developing-type-2-diabete-21248 https://curecurrent.com/trials/profiling-of-original-cellular-and-humoral-biomarkers-of-type-1-diabetes-21249 https://curecurrent.com/trials/dose-range-finding-study-for-mk0893-0893-008-21250 https://curecurrent.com/trials/effect-of-stevioside-in-postpandrial-glucose-in-healthy-adults-21251 https://curecurrent.com/trials/community-health-worker-reduces-care-utilization-21252 https://curecurrent.com/trials/a-phase-1-single-dose-study-to-evaluate-the-safety-and-pharmacokinetics-of-medi0382-in-healthy-volunteers-21253 https://curecurrent.com/trials/type-2-diabetes-prevention-21254 https://curecurrent.com/trials/sex-differences-in-the-risk-of-cardiovascular-diseases-associated-with-diabetes-21255 https://curecurrent.com/trials/post-prandial-glucose-and-insulin-levels-in-type-2-diabetes-mellitus-patients-after-consumption-of-ready-to-eat-mixed-me-21256 https://curecurrent.com/trials/day-night-rhythm-in-human-skeletal-muscle-21257 https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-er-niacin-laropiprant-laropiprant-er-niacin-and-placebo-on-urinary-prostanoid-metabol-21258 https://curecurrent.com/trials/long-acting-insulin-glargine-titration-web-tool-lthome-vs-enhanced-usual-therapy-of-glargine-titration-21259 https://curecurrent.com/trials/comparison-of-effects-of-telmisartan-and-valsartan-on-neointima-volume-in-diabetes-21260 https://curecurrent.com/trials/ara290-in-t2d-effects-of-ara-290-an-erythropoietin-analogue-in-prediabetes-and-type-2-diabetes-21261 https://curecurrent.com/trials/evaluation-of-the-glucoregulatory-effects-of-glucagon-like-peptide-1-receptor-glp-1-receptor-activation-in-participants-21262 https://curecurrent.com/trials/oneshot-renal-denervation-registry-21263 https://curecurrent.com/trials/beneficial-effects-of-a-polyphenol-enriched-beverage-on-type-2-diabetes-prevention-and-on-cardiovascular-risk-profile-of-21264 https://curecurrent.com/trials/glycaemic-alterations-in-icu-21265 https://curecurrent.com/trials/effect-of-varying-the-protein-and-dietary-fiber-content-of-energy-bars-on-their-glycemic-and-insulinemic-impact-21266 https://curecurrent.com/trials/psychoneuroimmunology-therapy-in-uncontrolled-diabetic-patients-a-quasi-experimental-study-21267 https://curecurrent.com/trials/thiazolidinediones-or-sulphonylureas-and-cardiovascular-accidents-intervention-trial-21268 https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glargine-in-patients-with-type-2-diabetes-with-inadequate-control-on-dpp-4-inhibitor-ther-21269 https://curecurrent.com/trials/a-post-marketing-safety-study-of-sitagliptin-januvia-mk-0431-234-21270 https://curecurrent.com/trials/a-single-dose-study-of-mk6349-in-patients-with-type-2-diabetes-6349-002-21271 https://curecurrent.com/trials/a-study-of-the-current-medical-practice-and-outcomes-in-the-treatment-of-type-2-diabetes-mellitus-in-an-office-setting-m-21272 https://curecurrent.com/trials/clinical-trial-designed-to-determine-the-safety-and-efficacy-of-ema401-in-patients-with-painful-diabetic-neuropathy-21273 https://curecurrent.com/trials/pearl-program-empowerment-program-for-patients-with-type-2-diabetes-hk4-21274 https://curecurrent.com/trials/janumet-before-insulin-lantus-in-eastern-population-evaluation-program-jubilee-in-type-2-diabetic-patients-21275 https://curecurrent.com/trials/effects-of-disease-management-on-development-of-end-stage-renal-disease-in-type-2-diabetic-patients-with-nephropathy-21276 https://curecurrent.com/trials/the-effect-of-liraglutide-in-patients-with-prediabetes-and-kidney-failure-21277 https://curecurrent.com/trials/treatment-with-erythropoietin-and-cognition-during-hypoglycaemia-21278 https://curecurrent.com/trials/patient-experiences-with-injection-needles-21279 https://curecurrent.com/trials/a-survey-to-evaluate-the-rate-of-abnormal-glucose-tolerance-among-hong-kong-chinese-subjects-with-coronary-heart-disease-21280 https://curecurrent.com/trials/a-survey-on-the-rate-of-glucose-intolerance-in-hong-kong-chinese-21281 https://curecurrent.com/trials/a-survey-to-evaluate-the-cardiovascular-risk-status-of-subjects-with-pre-diabetes-in-hong-kong-21282 https://curecurrent.com/trials/prevalence-study-of-depression-in-chinese-patients-with-type-2-diabetes-hk13-21283 https://curecurrent.com/trials/safety-efficacy-of-sitagliptin-in-patient-w-type-2-diabetes-0431-801-21284 https://curecurrent.com/trials/bioavailability-of-a-fixed-dose-combination-tablet-with-empagliflozin-bi-10773-and-metformin-compared-with-the-monocompo-21285 https://curecurrent.com/trials/alpha-lipoic-acid-reduces-left-ventricular-mass-in-normotensive-type-2-diabetic-patients-with-coronary-artery-disease-21286 https://curecurrent.com/trials/evaluating-system-accuracy-and-user-performance-of-omnitest-blood-glucose-monitoring-systems-for-self-testing-in-managin-21287 https://curecurrent.com/trials/hematopoietic-stem-cell-support-versus-insulin-in-t1d-21288 https://curecurrent.com/trials/the-effects-of-atorvastatin-on-the-nitrogen-oxide-system-in-patients-with-type-2-diabetes-and-nephropathy-21289 https://curecurrent.com/trials/surgical-treatment-in-diabetic-patients-with-grade-1-obesity-21290 https://curecurrent.com/trials/comparison-of-glycaemic-fluctuation-and-oxidative-stress-between-two-short-term-therapies-for-type-2-diabetes-21291 https://curecurrent.com/trials/post-marketing-surveillance-study-12-to-24-weeks-study-on-the-treatment-emergent-adverse-events-in-patients-with-type-2-21292 https://curecurrent.com/trials/effects-of-curcumin-supplementation-on-lipid-profile-and-inflammatory-markers-of-patients-with-type-2-diabetes-21293 https://curecurrent.com/trials/a-study-of-the-effects-of-sitagliptin-mk0431-and-metformin-on-incretin-hormone-concentrations-0431-050-completed-21294 https://curecurrent.com/trials/metabolic-and-cardiovascular-effects-of-dipeptidyl-peptidase-4-dpp-4-or-sodium-glucose-co-transporter-type-2-sglt2-inhib-21295 https://curecurrent.com/trials/a-study-on-the-effect-of-kidney-disease-on-a-diabetes-medication-0431-008-21296 https://curecurrent.com/trials/effect-of-the-extract-of-the-flour-fermented-with-bacillus-subtilis-var-natto-dc-15-on-postprandial-glucose-21297 https://curecurrent.com/trials/evaluation-of-continuous-glucose-monitoring-in-participants-with-type-2-diabetes-mellitus-mk-0000-258-am2-21298 https://curecurrent.com/trials/a-study-of-mk-0893-on-glucagon-induced-glycemic-excursion-in-healthy-male-participants-following-intravenous-administrat-21299 https://curecurrent.com/trials/study-of-the-bioequivalence-of-two-tablet-forms-of-mk0431-0431-027-21300 https://curecurrent.com/trials/pioglitazone-regress-left-ventricular-mass-in-type-2-diabetes-with-ischeamia-heart-disease-21301 https://curecurrent.com/trials/ocustem-nutritional-supplement-in-diabetic-patients-with-mild-to-moderate-non-proliferative-retinopathy-21302 https://curecurrent.com/trials/an-open-label-multi-center-randomized-parallel-group-study-comparing-the-efficacy-and-safety-of-insulin-viaject-and-regu-21303 https://curecurrent.com/trials/sitagliptin-reduces-left-ventricular-mass-in-normotensive-type-2-diabetic-patients-with-coronary-artery-disease-21304 https://curecurrent.com/trials/effects-of-intranasal-oxytocin-and-vasopressin-on-social-behavior-and-decision-making-21305 https://curecurrent.com/trials/the-effects-of-exenatide-on-oral-contraceptive-pharmacokinetics-in-healthy-females-21306 https://curecurrent.com/trials/effects-of-rosiglitazone-and-metformin-on-metabolism-in-type-2-diabetes-21307 https://curecurrent.com/trials/physical-activity-in-children-with-type-1-diabetes-study-21308 https://curecurrent.com/trials/effect-of-atorvastatin-on-glycemic-control-in-prediabetic-patients-21309 https://curecurrent.com/trials/effect-of-statin-treatment-on-urinary-aqp2-uaqp2-01-21310 https://curecurrent.com/trials/safety-and-tolerability-efficacy-pharmacokinetic-and-pharmacodynamic-study-of-three-doses-of-bi-187004-over-28-days-in-p-21311 https://curecurrent.com/trials/cold-stress-stimulate-the-browing-of-subcutaneous-white-adipose-in-healthy-adults-21312 https://curecurrent.com/trials/sitagliptin-metformin-fed-bioequivalence-study-0431a-080-21313 https://curecurrent.com/trials/3-month-trial-observation-of-a1c-change-21314 https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-4-doses-of-imeglimin-after-24-weeks-of-treatment-in-subjects-with-type-2-diabetes-21315 https://curecurrent.com/trials/study-to-identify-adequate-biomarker-to-detect-vitamin-b12-deficiency-in-type-2-diabetic-patients-treated-with-metformin-21316 https://curecurrent.com/trials/perioperative-hyperglycaemia-in-primary-total-hip-and-knee-replacement-21317 https://curecurrent.com/trials/a-post-marketing-safety-study-of-sitagliptin-phosphate-metformin-hydrochloride-janumet-mk-0431a-235-21318 https://curecurrent.com/trials/evaluation-of-morbidities-endpoints-and-reaching-targets-in-diabetic-patients-managed-by-a-diabetes-specialist-team-21319 https://curecurrent.com/trials/comparison-of-two-new-generation-drug-eluting-stents-in-patients-with-diabetes-oct-des-21320 https://curecurrent.com/trials/importance-in-type-1-diabetes-patients-of-an-optimized-control-of-post-prandial-glycaemia-on-oxidant-stress-prevention-21321 https://curecurrent.com/trials/syringes-replacement-for-insulin-application-for-pens-device-in-a-population-of-elderly-patients-with-type-2-diabetes-mu-21322 https://curecurrent.com/trials/phenotypic-and-genetic-correlates-of-diabetes-non-type-1-in-young-non-obese-asian-indians-in-north-india-and-a-study-to-21323 https://curecurrent.com/trials/paramedical-consultation-in-telemedicine-21324 https://curecurrent.com/trials/empowerment-and-support-for-the-diabetic-patient-21325 https://curecurrent.com/trials/human-adipose-derived-mesenchymal-stem-cells-for-critical-limb-ischemia-cli-in-diabetic-patients-21326 https://curecurrent.com/trials/effect-of-diabetes-mellitus-on-success-of-spinal-anesthesia-21327 https://curecurrent.com/trials/safety-and-tolerability-of-lixisenatide-in-combination-with-oral-anti-diabetic-treatment-in-patients-with-type-2-diabete-21328 https://curecurrent.com/trials/effect-of-treatment-with-insulin-viajecttm-compared-to-regular-human-insulin-and-insulin-lispro-on-mealtime-blood-vessel-21329 https://curecurrent.com/trials/an-evaluation-of-the-effectiveness-and-acceptability-of-delivering-structured-care-in-chinese-type-2-diabetic-patients-21330 https://curecurrent.com/trials/an-open-label-multi-center-randomized-parallel-group-study-comparing-the-efficacy-and-safety-of-insulin-viaject-and-regu-21331 https://curecurrent.com/trials/effects-of-an-exercise-program-among-cf-patients-with-dysglycemia-21332 https://curecurrent.com/trials/electrical-stimulation-and-expression-of-vegf-vegfr-2-hif-and-no-in-the-diabetic-foot-ulcer-21333 https://curecurrent.com/trials/askina-calgitrol-paste-diabetic-foot-ulcers-21334 https://curecurrent.com/trials/metabolic-and-therapeutic-effects-of-american-and-korean-red-ginseng-in-the-treatment-of-type-2-diabetes-21335 https://curecurrent.com/trials/skin-ulcers-treatment-with-an-handicraft-topical-device-21336 https://curecurrent.com/trials/osteoprosis-in-type-2-diabetic-patients-a-cohort-study-21337 https://curecurrent.com/trials/validation-of-the-artificial-pancreas-diabeloop-algorithm-in-the-hospital-21338 https://curecurrent.com/trials/effect-of-soy-protein-and-polydextrose-on-food-intake-in-young-chinese-adult-males-21339 https://curecurrent.com/trials/galvus-vildagliptin-vs-placebo-in-combination-with-metformin-and-insulin-21340 https://curecurrent.com/trials/dexmedetomidine-affect-diabetic-patient-s-glucose-metabolism-21341 https://curecurrent.com/trials/an-open-label-multi-center-follow-on-study-examining-the-long-term-safety-and-efficacy-of-insulin-viaject-in-subjects-wi-21342 https://curecurrent.com/trials/an-open-label-multi-center-follow-on-study-examining-the-long-term-safety-and-efficacy-of-insulin-viaject-in-subjects-wi-21343 https://curecurrent.com/trials/effectiveness-of-individualized-exercise-program-combined-with-a-balanced-diet-on-the-evolution-of-body-fat-21344 https://curecurrent.com/trials/coronary-ct-angiography-in-asymptomatic-diabetes-mellitus-21345 https://curecurrent.com/trials/a-study-evaluating-the-bioequivalence-of-viaject-7-compared-to-viaject-25-and-comparing-the-pharmacokinetic-and-pharmaco-21346 https://curecurrent.com/trials/saxagliptin-s-effects-on-microalbuminuria-improvement-in-type-2-diabetic-patients-21347 https://curecurrent.com/trials/the-effect-of-administration-of-small-doses-of-thyroxine-on-glucose-and-lipid-metabolism-in-type-2-diabetes-mellitus-21348 https://curecurrent.com/trials/evaluation-of-low-blood-sugar-events-in-participants-with-diabetes-mk-0431-402-21349 https://curecurrent.com/trials/metabolic-effects-of-accurate-blood-sugar-results-and-education-in-type-1-diabetes-21350 https://curecurrent.com/trials/bioequivalence-study-of-sitagliptin-metformin-combination-tablet-mk0431a-122-21351 https://curecurrent.com/trials/a-study-to-test-mk-0941-in-adults-with-type-2-diabetes-mellitus-with-inadequate-glycemic-control-on-insulin-mk-0941-018-21352 https://curecurrent.com/trials/safety-study-to-assess-whether-proinsulin-peptide-injections-can-slow-or-stop-the-body-damaging-its-own-insulin-making-c-21353 https://curecurrent.com/trials/duodenal-exclusion-for-the-treatment-of-type-2-diabetes-21354 https://curecurrent.com/trials/a-study-of-single-dose-pain-therapy-in-patients-with-painful-diabetic-neuropathy-0000-115-21355 https://curecurrent.com/trials/pharmacodynamic-and-pharmacokinetic-variability-of-a-basal-insulin-0000-168-21356 https://curecurrent.com/trials/the-effects-of-jerusalem-artichoke-and-fermented-soybean-powder-mixture-supplementation-on-glucose-control-21357 https://curecurrent.com/trials/effect-of-serving-size-and-addition-of-sugar-on-the-glycemic-response-elicited-by-oatmeal-21358 https://curecurrent.com/trials/bladder-cancer-screening-among-diabetic-patients-21359 https://curecurrent.com/trials/a-clinical-trial-to-investigate-safety-tolerability-and-pharmacokinetics-of-da-1229-01-evogliptin-metformin-xr-2-5-500-m-21360 https://curecurrent.com/trials/the-significance-of-urine-uba52-in-the-diagnosis-of-diabetic-nephropathy-21361 https://curecurrent.com/trials/the-effect-of-the-glp-1-receptor-agonists-on-blood-levels-of-lipoprotein-a-21362 https://curecurrent.com/trials/effects-of-incretin-on-the-blood-pressure-and-lipid-in-patients-with-overweight-or-obese-diabetes-21363 https://curecurrent.com/trials/comparative-effectiveness-of-two-approaches-to-diabetes-management-in-the-uninsured-21364 https://curecurrent.com/trials/a-observational-study-to-evaluate-lipid-lowering-drug-its-effect-on-parameters-in-dyslipidemia-of-type-2-diabetes-21365 https://curecurrent.com/trials/effect-of-dapagliflozine-on-systemic-and-renal-endothelial-function-21366 https://curecurrent.com/trials/the-beta-cell-responsiveness-to-glucose-dependent-insulinotropic-polypeptide-gip-with-and-without-sulfonylurea-in-patien-21367 https://curecurrent.com/trials/the-drug-drug-interaction-of-shr3824-and-metformin-21368 https://curecurrent.com/trials/effect-of-gemigliptin-or-acarbose-on-endothelial-function-in-type-2-dm-patients-21369 https://curecurrent.com/trials/an-investigational-drug-study-in-adults-with-type-2-diabetes-on-basal-insulin-mk-0941-006-21370 https://curecurrent.com/trials/glucose-dependent-insulinotropic-polypeptide-new-role-as-blood-glucose-stabilizer-21371 https://curecurrent.com/trials/gip-and-glp-1-in-type-1-diabetes-21372 https://curecurrent.com/trials/investigating-efficacy-and-safety-of-biphasic-insulin-aspart-50-twice-daily-versus-biphasic-human-insulin-50-twice-daily-21373 https://curecurrent.com/trials/to-compare-the-similarity-of-a-combination-dapagliflozin-metformin-tablet-with-the-two-drugs-administered-separately-21374 https://curecurrent.com/trials/home-versus-hospital-care-in-glucose-monitoring-of-gestational-diabetes-and-mild-gestational-hyperglycemia-21375 https://curecurrent.com/trials/efficacy-and-safety-of-lobeglitazone-versus-sitagliptin-21376 https://curecurrent.com/trials/randomized-translational-study-to-examine-the-effects-of-shared-care-in-management-of-gestational-diabetes-21377 https://curecurrent.com/trials/epidemiological-study-on-the-relationship-between-respiratory-health-and-air-pollution-from-industrial-sources-21378 https://curecurrent.com/trials/remote-simultaneous-medical-interpreting-and-medical-outcomes-21379 https://curecurrent.com/trials/a-study-of-absorption-metabolism-excretion-and-mass-balance-after-a-single-dose-administration-of-mk-0941-mk-0941-016-co-21380 https://curecurrent.com/trials/monotherapy-study-in-patients-with-type-2-diabetes-mellitus-0431-021-21381 https://curecurrent.com/trials/a-single-dose-crossover-study-of-mk0893-in-patients-with-type-2-diabetes-0893-019-am4-completed-21382 https://curecurrent.com/trials/comparison-of-anesthetic-modalities-on-hemodynamic-stability-and-postoperative-pain-in-diabetic-foot-patients-undergoing-21383 https://curecurrent.com/trials/sulfonylurea-add-on-study-in-patients-with-type-2-diabetes-mellitus-0431-035-21384 https://curecurrent.com/trials/the-empowerment-model-towards-type-2-diabetic-adults-to-enhance-vegetable-intake-in-achieving-glycemic-control-21385 https://curecurrent.com/trials/effectiveness-of-nigella-sativa-kalonji-seed-in-dyslipidemia-21386 https://curecurrent.com/trials/multi-centre-peer-support-program-in-type-2-diabetes-patients-in-hong-kong-21387 https://curecurrent.com/trials/multicomponent-telecare-model-for-supporting-prediabetes-patients-21388 https://curecurrent.com/trials/assessment-of-blood-glucose-monitoring-systems-21389 https://curecurrent.com/trials/the-phase-i-clinical-study-to-evaluate-the-pharmacokinetics-of-dw1029m-in-healthy-male-volunteer-21390 https://curecurrent.com/trials/the-inhibitory-effect-of-metformin-on-gluconeogenesis-in-relation-to-polymorphisms-in-organic-cation-transporter-1-21391 https://curecurrent.com/trials/the-role-of-small-intestinal-endocrine-cells-in-type-2-diabetic-hyperglucagonemia-21392 https://curecurrent.com/trials/telemonitoring-system-study-in-participants-with-type-2-diabetes-mellitus-mk-0000-347-21393 https://curecurrent.com/trials/community-health-assessment-program-in-the-philippines-21394 https://curecurrent.com/trials/effectiveness-of-a-treat-to-target-clinic-led-by-a-nurse-consultants-21395 https://curecurrent.com/trials/efficacy-and-tolerability-of-mk0533-in-patients-with-type-2-diabetes-0533-005-21396 https://curecurrent.com/trials/sustained-effects-of-a-non-glucidic-nutrient-preload-on-glucose-tolerance-in-type-2-diabetes-21397 https://curecurrent.com/trials/regulatory-t-cells-in-type-1-diabetes-patients-treated-with-il-2-21398 https://curecurrent.com/trials/mk0767-added-to-insulin-therapy-in-patients-with-type-2-diabetes-0767-030-21399 https://curecurrent.com/trials/clinical-evaluation-of-daptomycin-bone-penetration-21400 https://curecurrent.com/trials/consequences-of-human-inactivity-21401 https://curecurrent.com/trials/incretin-effect-and-use-after-clinical-islet-transplantation-21402 https://curecurrent.com/trials/a-study-to-evaluate-azp531-in-healthy-volunteers-overweight-obese-volunteers-and-patients-with-type-2-diabetes-mellitus-21403 https://curecurrent.com/trials/analytical-performance-evaluation-of-blood-glucose-monitoring-systems-investigator-sponsored-contour-xt-comparator-study-21404 https://curecurrent.com/trials/effects-on-exercise-hemodynamics-of-vasopressin-blockade-by-conivaptan-infusion-in-heart-failure-patients-21405 https://curecurrent.com/trials/autologous-endothelial-progenitor-cells-treatment-of-diabetic-foot-21406 https://curecurrent.com/trials/placebo-controlled-metformin-and-sulfonylurea-combination-study-in-patients-with-type-2-diabetes-0767-025-21407 https://curecurrent.com/trials/mk0767-and-metformin-combination-study-0767-028-21408 https://curecurrent.com/trials/functional-ingredients-effect-in-gastrointestinal-system-21409 https://curecurrent.com/trials/the-relation-between-plasma-irisin-level-and-endothelial-dysfunction-in-type-2-diabetes-21410 https://curecurrent.com/trials/changes-of-endothelial-function-before-and-after-dsa-in-patients-with-diabetes-21411 https://curecurrent.com/trials/minimal-psychological-intervention-in-diabetes-patients-21412 https://curecurrent.com/trials/atp-release-and-sympathetic-nerve-activity-in-patients-with-type-ii-diabetes-21413 https://curecurrent.com/trials/effectiveness-of-a-computerised-prompt-for-primary-and-secondary-care-physicians-to-refer-or-refer-back-type-2-diabetes-21414 https://curecurrent.com/trials/mk0767-in-type-2-diabetes-0767-012-21415 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-exenatide-once-weekly-injection-compared-to-once-daily-insulin-in-type-2-di-21416 https://curecurrent.com/trials/assessment-of-the-efficacy-and-safety-of-lixisenatide-in-patients-with-type-2-diabetes-insufficiently-controlled-with-ba-21417 https://curecurrent.com/trials/the-effect-of-spinal-anesthesia-on-heart-rate-variability-in-diabetic-patients-21418 https://curecurrent.com/trials/mk0431-monotherapy-study-in-patients-with-type-2-diabetes-mellitus-0431-040-21419 https://curecurrent.com/trials/a-study-of-an-investigational-drug-sitagliptin-for-type-2-diabetes-mellitus-0431-044-21420 https://curecurrent.com/trials/study-mk0767-and-metformin-in-type-2-diabetic-patients-0767-020-21421 https://curecurrent.com/trials/mk0767-glipizide-comparator-cardiac-safety-study-0767-018-21422 https://curecurrent.com/trials/haptoglobin-phenotype-and-cardiovascular-complications-in-diabetic-patients-21423 https://curecurrent.com/trials/dyslipidemia-in-type-2-diabetes-0767-034-21424 https://curecurrent.com/trials/evaluating-safety-of-novopen-3-and-or-flexpen-devices-in-routine-clinical-practice-21425 https://curecurrent.com/trials/mk0767-and-sulfonylurea-combination-study-0767-027-21426 https://curecurrent.com/trials/acceptability-and-feasibility-of-an-act-based-group-to-improve-diabetes-self-management-21427 https://curecurrent.com/trials/effect-of-iron-reduction-by-phlebotomy-for-type-2-diabetes-21428 https://curecurrent.com/trials/bioequivalence-food-effect-saxa-dapa-dual-fixed-dose-combination-fdc-21429 https://curecurrent.com/trials/coronary-artery-calcification-in-type-1-diabetes-21430 https://curecurrent.com/trials/the-effects-of-antecedent-hypoglycemia-or-exercise-on-the-response-of-the-brain-to-subsequent-hypoglycemia-21431 https://curecurrent.com/trials/a-study-to-demonstrate-the-bioequivalence-of-sitagliptin-metformin-combination-tablets-and-co-administration-of-sitaglip-21432 https://curecurrent.com/trials/therapeutic-efficacy-of-abroma-agusta-in-hba1c-in-niddm-21433 https://curecurrent.com/trials/the-role-of-vitamin-d3-and-calcium-supplementation-in-attenuating-t2dm-severity-21434 https://curecurrent.com/trials/closing-the-loop-in-adults-with-sub-optimally-controlled-type-1-diabetes-under-free-living-conditions-21435 https://curecurrent.com/trials/efficacy-of-higher-cutting-rate-in-microincision-vitrectomy-for-proliferative-diabetic-retinopathy-21436 https://curecurrent.com/trials/intravitreal-bevacizumab-avastin-versus-intravitreal-dexamethasone-ozurdex-for-persistent-diabetic-macular-oedema-21437 https://curecurrent.com/trials/the-effect-of-glp-1-receptor-activation-on-central-reward-and-satiety-in-obesity-and-diabetes-21438 https://curecurrent.com/trials/low-level-laser-therapy-and-expression-of-vegf-no-vegfr-2-hif-1-in-diabetic-foot-ulcers-21439 https://curecurrent.com/trials/effect-of-exercise-on-risk-factors-of-elderly-women-21440 https://curecurrent.com/trials/investigation-of-the-pharmacokinetic-properties-of-biphasic-insulin-aspart-50-in-healthy-chinese-subjects-21441 https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0148-0000-0362-in-healthy-subj-21442 https://curecurrent.com/trials/the-effects-of-physical-training-and-glp-1-receptor-agonist-liraglutide-treatment-in-patients-with-type-2-diabetes-21443 https://curecurrent.com/trials/retreatment-of-chronic-hepatitis-c-non-responders-with-pegylated-interferon-alpha-plus-ribavirin-plus-pioglitazone-21444 https://curecurrent.com/trials/elevated-ffa-and-skeletal-muscle-lipid-content-21445 https://curecurrent.com/trials/cardiovascular-risk-factor-management-in-hiv-infection-21446 https://curecurrent.com/trials/markers-of-bone-status-in-diabetes-mellitus-type-1-and-type-2-21447 https://curecurrent.com/trials/understanding-and-appraising-the-new-medicine-service-in-england-21448 https://curecurrent.com/trials/atorvastatin-aspirin-oxidative-stress-coagulation-and-platelet-activation-indexes-21449 https://curecurrent.com/trials/the-use-of-a-community-based-organization-to-change-lifestyle-characteristics-related-to-non-communicable-diseases-21450 https://curecurrent.com/trials/meta-analysis-of-fructose-containing-sugar-sweetened-beverages-ssbs-and-weight-change-21451 https://curecurrent.com/trials/comparison-of-resin-salve-and-octenidine-in-patients-with-neuropathic-diabetic-foot-ulcers-21452 https://curecurrent.com/trials/meta-analyses-of-the-effect-of-dietary-pulses-on-acute-postprandial-metabolic-control-21453 https://curecurrent.com/trials/meta-analyses-of-the-effect-of-tree-nuts-on-glycemic-control-and-features-of-the-metabolic-syndrome-21454 https://curecurrent.com/trials/metformin-in-gestational-diabetes-mellitus-21455 https://curecurrent.com/trials/meta-analyses-of-fructose-and-cardiometabolic-risk-21456 https://curecurrent.com/trials/infants-of-diabetic-mothers-a-cohort-study-21457 https://curecurrent.com/trials/the-medicines-advice-service-evaluation-21458 https://curecurrent.com/trials/a-study-of-ly2189265-in-japanese-participants-with-type-2-diabetes-mellitus-21459 https://curecurrent.com/trials/evaluation-of-stendo-pulsating-suit-on-microcirculation-and-endothelial-function-in-diabetic-patients-21460 https://curecurrent.com/trials/the-mobile-diabetes-mgmt-study-with-type-2-diabetes-21461 https://curecurrent.com/trials/follow-up-study-of-complications-of-acute-pancreatitis-21462 https://curecurrent.com/trials/mk0916-in-patients-with-type-2-diabetes-and-metabolic-syndrome-0916-005-21463 https://curecurrent.com/trials/comparison-of-insulin-mix25-versus-mix50-21464 https://curecurrent.com/trials/retrospective-collection-of-effectiveness-and-safety-data-from-patients-treated-with-liraglutide-or-dpp-4-inhibitor-in-p-21465 https://curecurrent.com/trials/pharmaceutical-care-in-emergency-department-21466 https://curecurrent.com/trials/aliskiren-vs-hydrochlorothiazide-in-hypertensive-type-ii-diabetic-patients-on-resistance-arteries-21467 https://curecurrent.com/trials/losartan-versus-hydrochlorothiazide-in-reversing-remodeling-of-small-arteries-in-pre-hypertensive-pre-diabetic-subjects-21468 https://curecurrent.com/trials/progression-of-coronary-atherosclerosis-in-asymptomatic-diabetic-subjects-21469 https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-precrea-on-subjects-with-higher-than-normal-blood-sugar-levels-21470 https://curecurrent.com/trials/dynamic-responsiveness-of-insulin-secretory-parameters-to-sitagliptin-and-glimeperide-administration-in-type-2-dm-21471 https://curecurrent.com/trials/beta-cell-function-and-related-pharmacodynamics-of-hms5552-in-t2dm-patients-21472 https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-isis-gccrrx-in-type-2-diabetes-21473 https://curecurrent.com/trials/metabolic-effects-of-the-manipulation-of-nutrient-sequence-in-the-main-meals-in-type-2-diabetic-patients-21474 https://curecurrent.com/trials/effects-of-low-intensity-aerobic-exercise-on-the-microvascular-endothelial-function-of-patients-with-type-1-diabetes-21475 https://curecurrent.com/trials/the-impact-of-post-discharge-one-time-home-visit-bridging-the-gap-between-hospital-and-home-21476 https://curecurrent.com/trials/myocardial-metabolism-in-patients-with-dilated-cardiomyopathy-21477 https://curecurrent.com/trials/the-effect-of-antecedent-hypoglycaemia-on-2-adrenergic-sensitivity-21478 https://curecurrent.com/trials/the-efficacy-of-acarbose-and-metformin-on-blood-glucose-fluctuation-when-combined-with-premix-insulin-21479 https://curecurrent.com/trials/bioequivalence-study-of-fixed-dose-combinations-and-coadministered-individual-tablets-of-saxagliptin-metformin-brazil-21480 https://curecurrent.com/trials/an-intervention-to-improve-management-of-dyslipidemia-in-primary-care-21481 https://curecurrent.com/trials/locally-delivered-aloe-vera-gel-in-the-treatment-of-chronic-periodontitis-patients-with-diabetes-mellitus-21482 https://curecurrent.com/trials/neuropathic-pain-syndrome-patient-study-mk-0000-072-21483 https://curecurrent.com/trials/the-expert-system-voicediab-in-children-with-diabetes-21484 https://curecurrent.com/trials/mobile-unit-screening-of-pathologies-associated-with-chronic-diseases-feasibility-21485 https://curecurrent.com/trials/neurogenic-inflammation-in-diabetes-21486 https://curecurrent.com/trials/the-effect-of-yogurt-enriched-with-flaxseed-on-cardiovascular-risk-factors-in-type-2-diabetic-patients-21487 https://curecurrent.com/trials/the-effect-of-whey-protein-consumed-as-a-pre-meal-on-postprandial-lipemia-in-healthy-and-subjects-with-type-2-diabetes-21488 https://curecurrent.com/trials/the-effect-of-protein-quality-and-time-factor-by-consumption-of-a-pre-meal-on-postprandial-lipemia-in-subjects-with-the-21489 https://curecurrent.com/trials/vascular-reactivity-in-kidney-disease-patients-21490 https://curecurrent.com/trials/safety-and-efficacy-of-insulin-nph-compared-to-a-new-insulin-formulation-in-subjects-with-type-2-diabetes-21491 https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-during-exercise-in-adults-with-type-1-diabetes-21492 https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-60-hours-in-adults-with-type-1-diabetes-21493 https://curecurrent.com/trials/a-phase-2-study-exploring-the-safety-and-efficacy-of-novel-drug-treatment-in-subjects-with-diabetic-macular-edema-dme-21494 https://curecurrent.com/trials/comparison-of-a-plant-protein-diet-to-a-animal-protein-diet-emphasized-in-type-2-diabetics-21495 https://curecurrent.com/trials/gestational-diabetes-induction-versus-expectant-management-of-labour-21496 https://curecurrent.com/trials/mobile-phone-personalized-intervention-for-diabetes-21497 https://curecurrent.com/trials/bioequivalence-of-two-insulatard-formulations-in-healthy-subjects-21498 https://curecurrent.com/trials/continuous-glucose-sensing-at-the-site-of-subcutaneous-insulin-administration-21499 https://curecurrent.com/trials/efficacy-and-safety-of-v0111-cream-on-open-cracked-heel-in-diabetic-patients-with-polyneuropathy-21500 https://curecurrent.com/trials/study-to-compare-the-efficacy-and-safety-of-administration-of-the-fix-dose-combination-of-linagliptin-plus-metformin-in-21501 https://curecurrent.com/trials/efficacy-of-spironolactone-in-cameroonian-diabetic-patients-with-resistant-hypertension-21502 https://curecurrent.com/trials/comparison-of-pioglitazone-versus-glimepiride-in-type-2-diabetes-inadequately-controlled-with-metformin-plus-alogliptin-21503 https://curecurrent.com/trials/contribution-of-nuclear-magnetic-resonance-imaging-in-the-study-of-diabetic-cardiomyopathy-21504 https://curecurrent.com/trials/metabolic-clock-genes-during-fasting-and-after-food-intake-in-type-2-diabetics-21505 https://curecurrent.com/trials/study-of-effectiveness-of-telemedicine-in-identifying-diabetic-retinopathy-cases-21506 https://curecurrent.com/trials/estimation-of-glomerular-filtration-rate-gfr-in-patients-with-type-2-diabetes-mellitus-21507 https://curecurrent.com/trials/the-obstacle-hypoglycemia-study-mk-0000-158-21508 https://curecurrent.com/trials/arginase-inhibition-in-ischemia-reperfusion-injury-21509 https://curecurrent.com/trials/effects-of-vitamin-d-supplementation-in-subjects-with-new-onset-of-type-1-diabetes-21510 https://curecurrent.com/trials/the-impact-of-rosuvastatin-on-the-density-score-of-coronary-artery-calcification-in-cad-patients-with-diabetes-mellitus-21511 https://curecurrent.com/trials/dpp-iv-inhibition-prior-to-development-of-diabetes-in-patients-with-cystic-fibrosis-21512 https://curecurrent.com/trials/md-logic-artificial-pancreas-for-automatic-type-1-diabetes-meals-management-21513 https://curecurrent.com/trials/screening-and-understanding-of-the-pre-diabetes-decodiab-21514 https://curecurrent.com/trials/durban-diabetes-study-a-study-of-the-epidemiology-of-diabetes-mellitus-in-urban-south-africans-of-african-descent-dds-21515 https://curecurrent.com/trials/bevacizumab-versus-ranibizumab-for-diabetic-retinopathy-21516 https://curecurrent.com/trials/safety-and-efficacy-of-biphasic-human-insulin-compared-to-ex1000-in-type-2-diabetes-21517 https://curecurrent.com/trials/markers-and-mechanisms-of-macrovascular-disease-in-iddm-21518 https://curecurrent.com/trials/effect-of-pioglitazone-on-left-ventricular-diastolic-function-in-type-2-diabetes-mellitus-21519 https://curecurrent.com/trials/functional-mri-biomarkers-of-cognitive-decrements-in-diabetes-21520 https://curecurrent.com/trials/interactive-tool-to-support-self-management-through-lifestyle-feedback-aimed-at-physical-activity-of-copd-dm-patients-21521 https://curecurrent.com/trials/safety-and-tolerability-of-lixisenatide-in-monotherapy-in-patients-with-type-2-diabetes-21522 https://curecurrent.com/trials/renal-and-systemic-effects-of-ncx4016-in-patients-with-type-2-diabetes-and-early-nephropathy-21523 https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-once-weekly-versus-liraglutide-in-subjects-with-type-2-diabetes-21524 https://curecurrent.com/trials/choice-changes-to-treatment-and-outcomes-in-patients-with-type-2-diabetes-initiating-injectable-therapy-21525 https://curecurrent.com/trials/effectiveness-and-safety-of-early-stage-amputation-and-external-herbs-chitosan-for-diabetic-foot-ulcer-21526 https://curecurrent.com/trials/a-survey-on-hypoglycaemia-among-insulin-treated-patients-with-diabetes-21527 https://curecurrent.com/trials/exenatide-and-basal-insulins-use-in-the-real-setting-an-observational-study-in-patients-with-type-2-diabetes-21528 https://curecurrent.com/trials/a-comparison-of-adding-exenatide-with-switching-to-exenatide-in-patients-with-type-2-diabetes-experiencing-inadequate-gl-21529 https://curecurrent.com/trials/a-study-to-examine-the-effects-of-exenatide-once-weekly-injection-on-glucose-control-and-safety-in-asian-subjects-21530 https://curecurrent.com/trials/efficacy-and-safety-of-exenatide-in-japanese-patients-with-type-2-diabetes-who-are-treated-with-oral-antidiabetic-s-21531 https://curecurrent.com/trials/delapril-and-manidipine-for-nephroprotection-in-diabetes-demand-21532 https://curecurrent.com/trials/renal-effect-of-pentoxyphylline-in-high-risk-patients-undergoing-angiography-21533 https://curecurrent.com/trials/desmopressin-as-treatment-for-postoperative-bleeding-after-cardiac-surgery-21534 https://curecurrent.com/trials/breakfast-on-postprandial-hyperglycemia-21535 https://curecurrent.com/trials/non-surgical-periodontal-therapy-effects-metabolic-control-in-diabetics-21536 https://curecurrent.com/trials/empagliflozin-add-on-to-insulin-in-type-1-diabetes-mellitus-over-28-days-21537 https://curecurrent.com/trials/community-based-multiple-risk-factors-intervention-strategy-21538 https://curecurrent.com/trials/effects-of-exenatide-and-insulin-glargine-in-subjects-with-type-2-diabetes-21539 https://curecurrent.com/trials/an-exploratory-study-of-the-effect-of-treatment-interruption-on-safety-of-exenatide-in-patients-with-type-2-diabetes-21540 https://curecurrent.com/trials/a-trial-comparing-two-therapies-basal-insulin-glargine-exenatide-and-metformin-therapy-bet-or-basal-insulin-glargine-bol-21541 https://curecurrent.com/trials/evaluation-of-retinal-changes-in-systemic-darbepoetin-alpha-treatment-in-patients-with-diabetes-mellitus-21542 https://curecurrent.com/trials/effect-of-exenatide-plus-metformin-vs-insulin-aspart-plus-metformin-on-glycemic-control-and-hypoglycemia-in-patients-wit-21543 https://curecurrent.com/trials/double-blind-placebo-study-of-jardiance-empagliflozin-in-prehypertensives-type-ii-diabetics-21544 https://curecurrent.com/trials/metabolic-effects-of-gh-and-igf-i-in-growth-hormone-deficient-ghd-and-diabetes-and-impaired-glucose-tolerance-igt-21545 https://curecurrent.com/trials/exenatide-compared-with-twice-daily-biphasic-insulin-aspart-in-patients-with-type-2-diabetes-using-sulfonylurea-and-metf-21546 https://curecurrent.com/trials/efficacy-of-once-weekly-exenatide-versus-once-or-twice-daily-insulin-detemir-in-patients-with-type-2-diabetes-21547 https://curecurrent.com/trials/incidence-of-hypoglycemia-during-ramadan-in-patients-with-type1-diabetes-on-insulin-pump-versus-multi-dose-injection-21548 https://curecurrent.com/trials/a-study-comparing-exenatide-with-basal-insulin-in-achieving-a-target-hba1c-with-minimum-weight-gain-in-type-2-diabetes-p-21549 https://curecurrent.com/trials/a-study-to-assess-the-effect-of-exenatide-treatment-on-mean-24-hour-heart-rate-in-patients-with-type-2-diabetes-21550 https://curecurrent.com/trials/post-marketing-surveillance-for-hypertensive-patients-with-diabetes-and-or-chronic-kidney-disease-21551 https://curecurrent.com/trials/effect-of-dexamethasone-implant-in-hard-exudate-complicated-with-diabetic-macular-edema-21552 https://curecurrent.com/trials/effects-of-fenofibrate-on-metabolic-and-reproductive-parameters-in-polycystic-ovary-syndrome-21553 https://curecurrent.com/trials/study-of-multiple-doses-of-saxagliptin-bms-477118-21554 https://curecurrent.com/trials/phase-iii-trial-to-evaluate-the-efficacy-and-safety-of-initial-combination-therapy-with-gemigliptin-50mg-q-d-and-metform-21555 https://curecurrent.com/trials/effects-of-jeju-red-horsehead-fish-based-high-protein-diet-on-satiety-and-incretin-hormones-in-diabetes-patients-21556 https://curecurrent.com/trials/an-investigational-drug-in-patients-with-type-2-diabetes-mellitus-and-chronic-renal-insufficiency-0431-028-completed-21557 https://curecurrent.com/trials/effects-of-pioglitazone-in-type-2-diabetes-mellitus-and-coronary-heart-disease-21558 https://curecurrent.com/trials/liraglutide-as-add-on-to-insulin-in-type-1-diabetes-21559 https://curecurrent.com/trials/genetic-susceptibility-factor-as-a-predictor-of-type-2-diabetes-remission-and-weight-loss-after-bariatric-surgery-21560 https://curecurrent.com/trials/a-comparison-of-strict-glucose-control-with-usual-care-at-the-time-of-islet-cell-transplantation-21561 https://curecurrent.com/trials/does-vitamin-d-improve-glycemic-control-in-type-ii-dm-21562 https://curecurrent.com/trials/the-impact-of-the-glycaemic-index-gi-on-daily-blood-glucose-profiles-and-food-intake-in-young-chinese-adult-males-21563 https://curecurrent.com/trials/pleiotropic-effects-of-azilsartan-medoxomil-over-insulin-resistance-in-obese-diabetic-and-hypertensive-patients-21564 https://curecurrent.com/trials/efficacy-and-safety-of-dapagliflozin-in-combination-with-metformin-in-type-2-diabetes-patients-21565 https://curecurrent.com/trials/influence-of-regular-exercise-and-detraining-on-metabolic-and-emotional-parameters-in-diabetic-individuals-21566 https://curecurrent.com/trials/substituting-brown-rice-for-white-rice-effect-on-diabetes-risk-factors-in-india-21567 https://curecurrent.com/trials/study-of-comparison-the-treatment-effect-between-gastric-bypass-and-exenatide-in-type-2-diabetes-21568 https://curecurrent.com/trials/feasibility-study-to-determine-the-optimal-calibration-method-for-glucose-sensors-21569 https://curecurrent.com/trials/wound-healing-process-in-diabetic-neuropathy-and-diabetic-neuroischemia-21570 https://curecurrent.com/trials/ontario-printed-educational-materials-pems-for-physician-behaviour-change-21571 https://curecurrent.com/trials/comparison-of-liraglutide-inhaled-into-the-lungs-compared-to-liraglutide-injected-under-the-skin-in-healthy-male-volunte-21572 https://curecurrent.com/trials/treatment-of-low-blood-sugar-with-glucagon-among-patients-with-type-1-diabetes-21573 https://curecurrent.com/trials/randomized-study-of-intravenous-immunoglobulin-ivig-in-patients-with-subacute-proximal-diabetic-neuropathy-21574 https://curecurrent.com/trials/medical-nutrition-therapy-plus-transgestational-metformin-for-preventing-gestational-diabetes-in-high-risk-mexican-women-21575 https://curecurrent.com/trials/pet-ct-scanning-for-the-follow-up-of-antibiotic-treatment-of-infectious-osteoarthritis-in-the-diabetic-foot-21576 https://curecurrent.com/trials/blood-pressure-outcomes-with-liraglutide-therapy-21577 https://curecurrent.com/trials/trendy-follow-up-study-on-endothelial-function-in-subjects-with-type-2-diabetes-mellitus-21578 https://curecurrent.com/trials/exercise-in-type-1-diabetes-mellitus-21579 https://curecurrent.com/trials/glyburide-and-metformin-for-the-treatment-of-gestational-diabetes-mellitus-systematic-review-21580 https://curecurrent.com/trials/laser-versus-vitrectomy-versus-intravitreal-triamcinolone-injection-for-diabetic-macular-edema-21581 https://curecurrent.com/trials/effect-of-quercetin-supplements-on-healthy-males-a-four-week-randomized-cross-over-trial-21582 https://curecurrent.com/trials/comparison-of-repaglinide-and-metformin-combination-tablet-versus-repaglinide-and-metformin-as-separate-tablets-in-healt-21583 https://curecurrent.com/trials/endobarrier-versus-intragastric-balloon-in-obese-diabetic-patients-21584 https://curecurrent.com/trials/cpap-in-diabetes-type-2-patients-with-sleep-apnea-21585 https://curecurrent.com/trials/phase-i-multiple-ascending-dose-japan-21586 https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-food-effect-of-mk-0941-in-adults-with-type-2-diabetes-mk-0941-009-21587 https://curecurrent.com/trials/efficacy-of-dorzolamide-as-an-adjuvant-after-focal-photocoagulation-in-clinically-significant-macular-edema-21588 https://curecurrent.com/trials/eeg-changes-of-type1-diabetes-during-sleep-insulin-induced-hypoglycemia-21589 https://curecurrent.com/trials/topic-antiinflammatory-therapy-added-to-selective-photocoagulation-in-macular-edema-21590 https://curecurrent.com/trials/effect-of-coadministration-of-ume-paste-prunus-mume-and-ginger-powder-21591 https://curecurrent.com/trials/prospective-randomized-open-label-phase-ii-study-to-assess-efficacy-and-safety-of-macugen-pegaptanib-0-3-mg-intravitreal-21592 https://curecurrent.com/trials/inpatient-evaluation-of-the-md-logic-artificial-pancreas-system-in-patients-with-type-1-diabetes-21593 https://curecurrent.com/trials/open-label-study-to-evaluate-long-term-treatment-effect-of-diapep277-21594 https://curecurrent.com/trials/bioequivalence-of-two-mixtard-30-formulations-in-healthy-subjects-21595 https://curecurrent.com/trials/study-to-test-software-algorithm-for-insulin-therapy-and-new-glucose-sensor-21596 https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-insulin-sensitivity-in-chinese-type-2-diabetic-patients-21597 https://curecurrent.com/trials/roles-of-t-helper-1-cytokines-in-type-1-diabetes-21598 https://curecurrent.com/trials/impact-of-individualized-structured-information-provision-to-the-patients-on-diabetes-related-outcomes-21599 https://curecurrent.com/trials/neuragen-for-peripheral-diabetic-neuropathy-21600 https://curecurrent.com/trials/open-label-investigation-of-the-safety-and-efficacy-of-diabecell-in-patients-with-type-1-diabetes-mellitus-21601 https://curecurrent.com/trials/lipid-lowering-with-highly-potent-statins-in-hyperlipidaemia-with-type-2-diabetes-patients-21602 https://curecurrent.com/trials/impact-of-elka-the-toolset-for-food-exchanges-calculation-on-metabolic-control-in-pediatric-diabetic-patients-21603 https://curecurrent.com/trials/prevalence-and-risk-factors-of-erectile-dysfunction-in-type-2-diabetic-patients-21604 https://curecurrent.com/trials/weight-trajectory-in-new-users-of-sulfonylureas-as-add-on-therapy-next-to-metformin-21605 https://curecurrent.com/trials/effects-of-gemigliptin-versus-sitagliptin-or-glimepiride-with-metformin-on-glucose-variability-mage-glucose-sd-patients-21606 https://curecurrent.com/trials/urokinase-therapy-in-patients-with-diabetic-foot-syndrome-21607 https://curecurrent.com/trials/study-on-exploring-the-effect-of-dpp-4-inhibitors-on-cell-function-by-using-the-two-step-hyperglycemic-clamp-21608 https://curecurrent.com/trials/behavioral-lifestyle-intervention-study-blis-in-patients-with-type-2-diabetes-in-uae-a-randomized-controlled-trial-in-re-21609 https://curecurrent.com/trials/mk-0941-multiple-dose-study-in-japanese-patients-with-type-2-diabetes-mk-0941-011-21610 https://curecurrent.com/trials/accu-chek-combo-in-young-patients-21611 https://curecurrent.com/trials/maximising-the-taste-and-health-value-of-plant-food-products-21612 https://curecurrent.com/trials/retinal-function-in-relation-to-transient-or-chronic-challenges-to-retinal-metabolism-21613 https://curecurrent.com/trials/aloe-vera-in-chronic-periodontitis-with-type-2-diabetes-mellitus-21614 https://curecurrent.com/trials/retinal-adaptation-to-intensified-insulin-therapy-and-bariatric-surgery-in-patients-with-diabetes-21615 https://curecurrent.com/trials/effect-of-short-term-intensive-insulin-sequential-exenatide-therapy-in-newly-diagnosed-type-2-diabetic-patients-21616 https://curecurrent.com/trials/prevention-of-hypoglycaemia-with-predictive-insulin-suspend-using-sensor-augmented-insulin-pump-in-children-21617 https://curecurrent.com/trials/effect-of-low-gi-glycemic-load-gl-diet-in-diabetic-nephropathy-patients-21618 https://curecurrent.com/trials/long-term-mortality-in-diabetics-undergoing-major-surgery-21619 https://curecurrent.com/trials/effects-of-low-or-high-glycemic-index-diets-on-metabolic-and-inflammatory-responses-in-diabetics-21620 https://curecurrent.com/trials/a-pharmacokinetic-study-of-mk-0941-after-multiple-daily-doses-in-subjects-with-type-2-diabetes-mk-0941-012-completed-21621 https://curecurrent.com/trials/changing-diabetes-in-children-21622 https://curecurrent.com/trials/sitagliptin-metformin-janumet-re-examination-study-0431a-182-21623 https://curecurrent.com/trials/optimized-glycemic-control-in-heart-failure-patients-with-dm2-effect-on-left-ventricular-function-and-skeletal-muscle-21624 https://curecurrent.com/trials/partnership-for-a-hispanic-diabetes-prevention-program-21625 https://curecurrent.com/trials/bone-marrow-as-an-alternative-site-for-islet-transplantation-21626 https://curecurrent.com/trials/efficacy-safety-of-pedyphar-ointment-in-diabetic-foot-ulcer-treatment-21627 https://curecurrent.com/trials/establishing-a-diabetes-registry-using-the-jade-diamond-electronic-portal-cn001-21628 https://curecurrent.com/trials/safety-study-of-multigeneangio-in-patients-with-chronic-critical-limb-ischemia-21629 https://curecurrent.com/trials/a-trial-investigating-the-pharmacodynamic-and-pharmacokinetic-properties-of-insulin-degludec-insulin-aspart-15-in-subjec-21630 https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-biphasic-insulin-aspart-30-and-biphasic-human-insulin-30-on-blood-sugar-control-in-21631 https://curecurrent.com/trials/adipocytokines-gestational-diabetes-mellitus-and-lipid-metabolism-21632